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IMPACT OF TIMING OF PROTEIN INTAKE ON NITROGEN BALANCE IN 
HYPOCALORIC EXERCISING OLDER INDIVIDUALS 
 
 We have previously shown that in older adults, consumption of protein 
immediately after aerobic exercise, rather than earlier in the day, enhances nitrogen 
balance when energy balance is maintained.  Since some older individuals consume lower 
calorie diets, it is important to know if these benefits also occur during hypocaloric 
feeding.  The purpose of the study was to investigate if consumption of protein 
immediately after aerobic exercise rather than earlier in the day can improve nitrogen 
balance in older individuals consuming a hypocaloric diet.  In a randomized crossover 
design, healthy sedentary male (n=2; age=67.0±1.0 years; BMI=27.4±0.3 kg/m²) and 
female (n=8; age=63.0±1.8 years; BMI=22.3±0.6 kg/m²) subjects completed two separate 
3-day exercise and nutrition interventions.  Exercise (60 minutes of stationary cycling at 
55% of VO2max) was performed daily.  Diets were hypocaloric (-15% daily intake), with a 
protein+carbohydrate (PRO+CHO) or carbohydrate only (CHO) drink consumed in the 
morning and the opposite drink consumed after exercise.  Both diets (15% protein, 30% 
fat, and 55% carbohydrate) were isonitrogenous and isocaloric with only the timing of the 
drinks differing.  A 24-hour stay in a metabolic chamber confirmed negative energy 
balance, while 24-hour urine collections determined nitrogen balance.  The 3-day mean
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nitrogen balance was not significantly greater in the PRO+CHO trial (0.097±0.526g N) 
trial than the CHO trial (-0.070 ±0.520g N) (p=0.280).  Thus, older individuals in 
negative energy balance do not maintain a significantly more positive nitrogen balance by 
consuming protein after aerobic exercise as opposed to earlier in the day.  These results 
differ from our previous work and indicate that energy balance is an important 
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Sarcopenia is the gradual reduction of skeletal muscle mass and function associated 
with aging.  While there is not an accepted clinical definition of sarcopenia, the most commonly 
used definition is based on a skeletal muscle mass index obtained by dividing appendicular 
skeletal muscle by body height squared (ASM/ht2) (Baumgartner, Koehler et al. 1998).  
Individuals with an ASM/ht2 ratio between one and two standard deviations of the gender-
specific young control are categorized as having class I sarcopenia and individuals exceeding two 
standard deviations are considered to have class II sarcopenia (Janssen, Heymsfield et al. 2002).  
The prevalence of class I sarcopenia is approximately 52%, whereas the prevalence of class II is 
about 8% in individuals aged 60 and older.  By the age of 70, the cross-sectional area of skeletal 
muscle can be reduced by up to 25-30% and muscle strength may be reduced by 30-40% 
(Porter, Vandervoort et al. 1995), with the loss of strength continuing to decrease at a rate of 1-
2% per year (Skelton, Greig et al. 1994).  The age-related loss of muscle mass and strength 
results in a decline in functional independence, physical disability, and mobility impairment 
(Janssen, Heymsfield et al. 2002).  Therefore, the sarcopenic older individual has greater 
difficulty doing basic activities of daily living, which increases their risk of falls and fractures.  
Sarcopenia also contributes to the pathogenesis of frailty, which is associated with increased 
hospitalizations, morbidity and mortality (Rolland, Czerwinski et al. 2008).  Although multiple 
lifestyle behaviors and mechanisms contribute to the development of sarcopenia, the loss of 
lean body mass is the result of differences in rates of protein breakdown and protein synthesis.
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The nitrogen balance method is commonly used to measure whole body protein 
balance.  Protein is the major nitrogen-containing substance within the body, and a gain or loss 
of nitrogen can be considered as synonymous with a gain or loss of protein (Calloway and 
Spector 1954).  When nitrogen intake exceeds the amount of nitrogen excreted, an individual is 
in positive nitrogen balance and when protein intake is less than the amount of nitrogen 
excreted negative nitrogen balance results.  Nitrogen balance is closely related to energy 
balance such that nitrogen balance is better maintained when caloric intake is adequate, as a 
negative nitrogen balance results when energy intake is reduced (Todd, Butterfield et al. 1984).  
During caloric restriction, protein breakdown increases the availability of amino acids that are 
oxidized as energy and thus limits the availability of amino acids for protein synthesis. 
Nutritional interventions that aim to maintain or increase lean body mass have primarily 
focused on increasing protein intake above the RDA of 0.8 g/kg bw.  The current RDA of 0.8 g/kg 
bw may not be adequate for older individuals as Campbell et al. have demonstrated that when 
older individuals in energy balance consumed the RDA for protein, negative nitrogen balance 
and loss of mid-thigh muscle area results (Campbell, Trappe et al. 2001).  However, in a recent 
study by Campbell et al., older individuals in energy balance maintained nitrogen balance with 
the RDA (Campbell, Johnson et al. 2008).  The recent study by Campbell et al. eliminated 
weaknesses of previous studies by including only healthy men and women subjects, using young 
subjects as a control group, and allowing adequate study time periods (Campbell, Johnson et al. 
2008).  Rather than increasing total protein intake, another approach to maximize net protein 
accretion in older individuals is to consume 25-30 grams of high quality protein per meal 
(Paddon-Jones and Rasmussen 2009).  Although increasing the absolute amount of protein is 
debatable, nutritional interventions represent a practical option for older individuals to maintain 
lean body mass.  In older individuals, exercise represents another strategy for maintaining lean 
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body mass.   Resistance exercise can increase muscle cross sectional area and strength in older 
individuals (Frontera, Meredith et al. 1988).  Additionally, recent studies have shown that 
aerobic exercise can also stimulate skeletal muscle protein synthesis (Wilkinson, Phillips et al. 
2008) and myofiber size and function (Harber, Konopka et al. 2009) in older individuals.  
Moreover, even when caloric intake is inadequate, aerobic exercise can increase nitrogen 
balance (Todd, Butterfield et al. 1984).  Because nutrition after exercise can take advantage of 
the anabolic period triggered by exercise (Miller, Olesen et al. 2005), combining nutrition with 
exercise may be the most effective strategy for preventing the loss of lean body mass in older 
individuals.  However, there is conflicting evidence as to whether timing protein intake after 
exercise results in enhanced protein synthesis and thus lean body mass (Rasmussen, Tipton et 
al. 2000; Tipton, Rasmussen et al. 2001).  In older individuals, protein consumption after aerobic 
exercise can increase whole body protein turnover (Murphy and Miller 2010) and nitrogen 
balance while in energy balance (Jordan, Melanson et al. 2010).  Since many older individuals 
are in negative energy balance (McDowell, Briefel et al. 1994), the current study investigated 
whether protein consumption after aerobic exercise, rather than earlier in the day, can improve 
nitrogen balance in older individuals in negative energy balance.    
Statement of the Problem: 
The purpose of the study is to investigate the effect of protein intake immediately after 
moderate intensity aerobic exercise rather than earlier in the day on nitrogen balance in 
hypocaloric older individuals. 
Hypothesis: 
  In older individuals in negative energy balance, timing protein consumption 
immediately after moderate aerobic exercise compared to earlier in the day will increase three-
day nitrogen balance. 
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Delimitations, Limitations, and Assumptions: 
 The study was delimited to 10 male and female subjects between the ages of 55-75 
years old.  All subjects were recruited from the Fort Collins and Loveland area and were 
Caucasian.   
There are limitations associated with the nitrogen balance technique, which includes 
potential overestimation of nitrogen balance (Hegsted 1976).  However, subjects are exposed to 
similar study conditions during both three-day trials, so nitrogen balance would be 
overestimated similarly.     
It was assumed that subjects fasted for 12-hours prior to their resting metabolic rate 
and blood draw.  Additionally, it is assumed that subjects consumed only meals provided by 
study staff during the lead-in and inpatient periods. 






Aging is associated with a progressive loss of physical independence, which leads to a 
significant reduction in the quality of life of older individuals.  A central contributor to frailty in 
older individuals is the loss of muscle mass, strength, and function.  Although multiple lifestyle 
behaviors and mechanisms contribute to the development of sarcopenia, the loss of lean body 
mass is the result of differences in rates of protein breakdown and protein synthesis.  Therefore, 
this review will first aim to review various topics associated with protein metabolism.  Then, the 
condition of sarcopenia will be defined and discussed, with an emphasis on potential causes of 
sarcopenia including decreased anabolic signaling, oxidative stress, and various lifestyle 
behaviors that may be responsible for the loss of lean body mass.  The next sections will then 
address the effect of nutrition, exercise, and energy balance on nitrogen balance and protein 
synthesis.  Lastly, nutritional and exercise interventions for the management of sarcopenia will 
be covered. 
Section 1: Amino Acids/Protein 
Amino acids play central roles both as building blocks of proteins and as intermediates 
in metabolism.  All amino acids have the same fundamental structure, which consists of a 
central carbon, an amino group, a carboxyl group and a unique side chain (R-group).  The 
carboxyl of one amino acid reacts with the amino group of another to form a peptide bond 
between the amino acids.  Amino acids joined together by peptide bonds form the primary 
structure of proteins.  Ten of the twenty amino acids are nonessential amino acids and can be 
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synthesized endogenously.  The remaining ten amino acids are essential amino acids that have 
to be obtained from the diet (Gropper, Smith et al. 2009).   
The digestion of ingested proteins starts in the stomach where hydrochloric acid 
denatures quaternary, tertiary and secondary structure of proteins, which allows the peptide 
bonds to be exposed to pepsin.  Within the stomach, pepsin hydrolyzes the peptide bonds 
between amino acids.  Protein digestion continues into the small intestine where pancreatic 
proteases continue to hydrolyze peptide bonds.   The combined action of gastric and pancreatic 
proteases digest proteins into oligopeptides and free amino acids.  Intestinal brush border 
enzymes further digest the oligopeptides prior to active absorption of free amino acids (Walker 
2000).  Dipeptides and tripeptides are also transported across the brush border of intestinal 
enterocytes via PEPT1 transport protein where they are further hydrolyzed by cytoplasmic 
peptidases to free intracellular amino acids.  Free amino acids not utilized by the enterocyte are 
transported through the basolateral membrane where they enter the portal vein and eventually 
reach systemic circulation (Gropper, Smith et al. 2009). 
Free amino acids derived from dietary protein sources and from degradation of body 
proteins both contribute to a pool of free amino acids.  This pool of free amino acids is 
maintained in order to supply tissues with a continuous supply of individual amino acids for the 
synthesis of new proteins and other nitrogen-containing compounds (Storey 2004).  There is 
constant turnover of protein, as some protein is constantly being synthesized while other 
protein is being degraded.  In basal situations (between meals), plasma amino acid 
concentrations remain relatively stable whereas the concentration increases following a meal 
(Dunford and Doyle 2008).  Similarly, protein synthesis increase in the fed state when the 
concentration of free amino acids increases.  Skeletal muscle, which acts as a major reservoir of 
amino acids, increases uptake of amino acids following ingestion of protein.  During this time, 
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protein synthesis is typically greater than protein degradation (Gropper, Smith et al. 2009).  
When caloric intake is inadequate, the overall breakdown of proteins, especially in skeletal 
muscle, increases to provide amino acids that are essential for new protein synthesis and energy 
production (Lecker, Solomon et al. 1999).  During a prolonged fast, amino acids derived from 
muscle protein are an important substrate for gluconeogenesis, which provides energy from 
non-carbohydrate sources (Ruderman 1975).   Despite differences in protein intake and rate of 
degradation of tissue protein, the concentration of the amino acids in the free amino acid pool 
remain relatively constant. 
Free amino acids are metabolized in response to various physiological states.  Amino 
acids in excess of the amount needed to synthesize protein and other nitrogen containing 
compounds undergo deamination or transamination reactions.  Transamination involves the 
transfer of an amine group from an amino acid to an α-keto acid.  Transamination reactions 
form nonessential amino acids from essential amino acids and other nonessential amino acids 
(Gropper, Smith et al. 2009).  When amino acids are deaminated, the amino group is removed as 
ammonia and an α-keto acid (carbon skeleton) is formed.  The α-keto acids can then be used as 
a substrate in energy producing pathways (gluconeogenesis) or to form fatty acids, which can 
then be utilized as energy or stored as fat (Lieberman, Marks et al. 2007).  The ammonia 
produced through deamination is converted to urea and excreted in urine (Gropper, Smith et al. 
2009).  When energy intake is inadequate, amino acids can be used for energy producing 
reactions.  When energy intake is in excess of the body’s energy needs fatty acids can be 






Section 2: Protein Metabolism 
Section 2.1: Protein Synthesis 
 Protein synthesis involves the transcription of deoxyribonucleic acid (DNA) to 
ribonucleic acid (RNA), and the translation of RNA to proteins.  Transcription begins when RNA 
polymerase binds to the promoter region of DNA.  Once bound to the promoter, RNA 
polymerase unwinds the DNA sequence and synthesizes an exact copy of the DNA strand.  The 
RNA transcript undergoes RNA processing, where a modified guanine cap is attached to the 5’ 
end and the 3’ end is polyadenylated.  The intron sequences are then removed from the RNA 
transcript.  The newly formed messenger RNA (mRNA) is then transported out of the nucleus 
into the cytoplasm, where translation occurs.  Translation is initiated by the binding of the 
eukaryotic initiation factor (eIF), eIF-4E, to the cap structure at the 5’ end of the mRNA.  The eIF-
4 complex is then recognized by a complex consisting of the 40S ribosomal subunit, the initiator 
transfer RNA (tRNA) and eIF-2.  The 40S subunit scans the mRNA for the initiator codon AUG 
(methionine) and attaches at that point.  Then the 60S ribosomal subunit binds to form the 80S 
ribosome, and translation is initiated.  Following initiation of the peptide chain, elongation 
occurs in which amino acids are joined to create a polypeptide chain.  During elongation, a 
specific eukaryotic elongation factor (eEF), eEF-1, recruits a tRNA with its associated amino acid 
to the ribosome.  A peptide bond is then formed between the carboxyl groups of the last amino 
acid with the new amino acid.  Subsequently, eEF-2 catalyzes the translocation of the ribosome 
three bases down the mRNA and the process of elongation is repeated.  Elongation continues 
until one of the three stop codons is encountered by the ribosome, at which point a eukaryotic 
releasing factor (eRF) cleaves the newly formed peptide (Latchman 2005).  Following the 
termination of translation, post-translational modifications occur that affect the final structure 
and function of the protein.  Post-translational modifications can involve the removal of one or 
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more amino acids from the peptide chain, addition of a side group, or the modification of a side 
group (Whitford 2005).  The multi-step process of protein synthesis results in the conversion of 
the genetic information within DNA into a protein. 
Section 2.2: Protein Breakdown 
The majority of intracellular protein is degraded by the ubiquitin-proteasomal system 
(Lecker, Solomon et al. 1999).  In the ubiquitin system, proteins that are to be degraded are 
ligated to ubiquitin in an ATP-requiring reaction.  Before ubiquitin can be linked to a protein, it 
must first be activated by the enzyme E1.  The newly activated ubiquitin is then transferred to 
the enzyme E2, which then transfers ubiquitin to the target protein in a reaction catalyzed by 
the E3 ubiquitin ligase.  Ubiquitinated proteins are subject to either further rounds of ubiquitin 
addition, or ubiquitin removal by deubiquitinating enzymes and degradation by the 26S 
proteasome, which breaks down targeted substrates to short peptides but recycles the ubiquitin 
molecules.  The 26S proteasome is a large multisubunit complex composed of a 20S 
proteasome, and a 19S regulatory particle.  The 19S regulatory particle recognizes and binds 
ubiquinated substrates, while the 20S proteasome degrades the target protein into amino acids 
(2009).        
In addition to the ubiquitin-proteasomal pathway, protein degradation also occurs via a 
lysosome mediated pathway.  The lysosomal pathway degrades proteins within the lysosome of 
the cell.  Lysosomes contain several acidic proteases that are capable of hydrolyzing 
endocytosed proteins.  Extracellular proteins brought into the cell by endocytosis, membrane 
bound proteins, and long-lived intracellular proteins are degraded in lysosomes in an ATP-
independent pathway.  Cytosolic proteins are degraded in lysosomes after being engulfed in 
autophagic vacuoles that fuse with lysosomes.  The lysosomal pathway is responsible for the 
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enhanced protein degradation observed during caloric restricted conditions (Gropper, Smith et 
al. 2009).   
In muscle, the calpain or calcium-activated protease pathway contributes to protein 
degradation.  µ-Calpain and m-calpain are the principle components of the calpain proteolytic 
pathway, and the activation of both proteases is modulated by intracellular calcium 
concentrations (Tavernarakis 2010).  The calpains are localized in the Z disk of the sarcomere, 
where they initiate the first step of degradation of muscle proteins.  Following the release of 
myofilaments from the myofibrils, the myofilament is then ligated to ubiquitin for further 
degradation via the ubiquitin-proteasomal pathway (Gropper, Smith et al. 2009).  Cells contain 
multiple proteolytic systems and complex regulatory mechanisms for the breakdown of 
proteins.    
Section 2.3: Protein Turnover   
 Protein turnover encompasses the simultaneous synthesis and degradation of proteins.  
The turnover of protein is an essential process that replaces damaged proteins that arise in cells 
due to spontaneous denaturation, errors in protein synthesis, errors in posttranslational 
processing, improper folding of the protein or due to damage caused by free radicals (Lecker, 
Solomon et al. 1999).  Additionally, protein turnover allows the body to rapidly alter the 
concentrations of specific proteins in response to various stimuli (Welle 1999).  Lastly, turnover 
of protein maintains the free amino acid pool, which allows the demands of protein synthesis to 
be met during times of energy restriction.  During times of energetic stress, protein degradation 
exceeds protein synthesis.  The body replaces previously catabolized proteins during periods of 
caloric or nitrogen excess, thereby maintaining a protein balance (Liu and Barrett 2002).  In 
weight stable individuals, whole body protein breakdown is approximately equal to whole body 
protein synthesis over a typical 24-hour period (Wagenmakers 1999).  When energy and protein 
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(amino acid) intake are adequate, protein breakdown is reduced and net protein synthesis 
results.   
The turnover rate of proteins can be determined using isotopically labeled tracers of 
amino acids.  The rate of protein turnover varies between tissues and differences also exist 
between the fractional synthesis rates of individual proteins (Wagenmakers 1999).   Protein 
turnover accounts for approximately 20% of an individuals’ resting metabolic rate with most of 
the energy being devoted to protein synthesis rather than proteolysis (Welle 1999).  In general, 
initial studies (Golden and Waterlow 1977; Lehmann, Johnston et al. 1989) have demonstrated 
reduced protein turnover rates with aging when values are expressed per kilogram body weight 
(Golden and Waterlow 1977; Lehmann, Johnston et al. 1989).  However, these studies did not 
account for the changes in body composition of the older individuals.  When protein turnover is 
expressed as protein turnover per kilogram of lean mass, there is no difference between the 
rates of protein turnover between young and older individuals in the postabsorptive state 
(Morais, Gougeon et al. 1997). Protein synthesis and degradation are closely regulated, and 
each is affected by various physiological conditions, such as fasting, feeding, exercise, and 
disease. 
Section 2.4: Negative Energy Balance and Protein Turnover 
 Protein turnover is affected by changes in energy balance.  In response to an acute (less 
than four days) hypocaloric feeding, whole body protein turnover is increased (Nair, Woolf et al. 
1987; Knapik, Meredith et al. 1991).  Whole body proteolysis increases while protein synthesis is 
decreased.  The increased protein breakdown increases the availability of amino acids that can 
be used as energy during an energy deficit.  The increase in amino acid oxidation, especially 
branched chain amino acids, also limits the availability of amino acids for protein synthesis.  The 
activity of AMP-activated protein kinase (AMPK), regarded as the energy sensor of the cell, 
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increases in response to the decrease in available energy, which also inhibits protein synthesis 
through the mammalian target of rapamycin (mTOR) pathway (Miyazaki and Esser 2009).  
During acute caloric restriction, vital organs are better able to maintain their respective 
synthetic rates compared to skeletal muscle.  An acute energy deprivation results in a 19% 
decrease in the synthetic rate of skeletal muscle, while the synthetic rate of the heart is 
maintained (Yuan, Sharma et al. 2008).  During prolonged (8 weeks) caloric restriction, whole 
body protein turnover is decreased (Hoffer, Bistrian et al. 1984).  However, there is conflicting 
research as to whether long term caloric restriction decreases protein turnover, as long term 
calorie restricted animals may have an increase in protein turnover (Lee, Klopp et al. 1999; 
Weindruch, Kayo et al. 2002).  Protein turnover is energetically costly, therefore when energy 
intake is reduced, protein turnover will be down regulated.   
Section 2.5: Skeletal Muscle Protein Turnover 
Proteins in skeletal muscle, as in all tissues, undergo a continuous process of 
degradation and synthesis.  Skeletal muscle is the major reservoir of the body’s amino acids as it 
contains over 60% of free amino acids (Wagenmakers 1999) and contributes about 30% to the 
whole body protein turnover (Nair 1995), despite a relatively low fractional synthetic rate (FSR) 
of approximately 1.15%/day (Wagenmakers 1999).  During starvation, muscle releases amino 
acids as a consequence of increased protein breakdown.  The amino acids that are released 
from muscle can be used for synthesis of essential acute phase proteins that turnover more 
quickly than skeletal muscle (Lecker, Solomon et al. 1999) and as substrates in energy producing 
pathways (Mitch and Goldberg 1996).  In the fed state, amino acids stimulate muscle protein 
synthesis, which results in a transition from net release (postabsorptive state) to net uptake of 
amino acids (postprandial state).  The relative contribution of muscle to whole body protein 
turnover increases during ingestion of mixed meals and after resistance exercise.  The muscle 
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contributes 35% to whole body protein turnover after consuming a mixed meal, and 
approximately 45% during ingestion of mixed meals after resistance exercise (Wagenmakers 
1999).  The anabolic effect of feeding and exercise allows skeletal muscle to replace proteins 
that were lost during times of energetic stress. 
Section 2.6: Skeletal Muscle Protein Metabolism in the Elderly 
Aging is associated with a progressive loss of muscle mass that occurs at a rate of 3 to 
8% per decade after the age of 30 and accelerates with advancing age (Genaro Pde and Martini 
2010).  The contribution of muscle protein to whole body protein metabolism is significantly 
reduced in the elderly.  Consequently, the contribution of non skeletal muscle protein, especially 
visceral tissue whose rates of protein turnover are known to be more rapid, is proportionally 
greater with aging (Morais, Chevalier et al. 2006).  The decreased skeletal muscle mass could 
reduce the capacity of the elderly to respond to restricted energy and protein intakes or to 
stressful conditions that require mobilization of amino acids from the muscle for protein 
synthesis.   
Essential amino acids are mainly responsible for the postprandial increase in muscle 
protein synthesis (Volpi, Kobayashi et al. 2003); however, the anabolic response of skeletal 
muscle proteins to essential amino acids is blunted in the elderly (Cuthbertson, Smith et al. 
2005).  In addition, skeletal muscle of older individuals is resistant to the anabolic action of 
insulin (Rasmussen, Fujita et al. 2006).  Although the exact mechanism for the impaired 
response to both essential amino acids and insulin are not currently known, both appear to act 
through the mTOR pathway.  In response to both essential amino acids and insulin, mTOR 
activation remains the same, but its downstream effector p70 ribosomal S6 kinase’s (p70s6k) 
activation is impaired (Guillet, Prod'homme et al. 2004).  The synthesis rate of mixed muscle 
protein and myosin heavy-chain is diminished in the elderly, which contributes to the decreased 
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contractile function of skeletal muscle in the elderly (Balagopal, Rooyackers et al. 1997).  Aging 
is also associated with a decreased rate of mitochondrial protein synthesis in skeletal muscle, 
which could result in decreased ATP availability and an increased susceptibility to fatigue 
(Rooyackers, Adey et al. 1996). 
Section 3: Sarcopenia 
Sarcopenia is the gradual reduction of skeletal muscle mass and function associated 
with aging.  While there is no accepted clinical definition of sarcopenia, the most commonly 
used definition is based on a skeletal muscle mass index obtained by dividing appendicular 
skeletal muscle by body height squared (ASM/ht2) (Baumgartner, Koehler et al. 1998).  
Individuals with an ASM/ht2 ratio between one and two standard deviations of the gender-
specific young control are categorized as having class I sarcopenia and individuals exceeding two 
standard deviations are considered to have class II sarcopenia (Janssen, Heymsfield et al. 2002).  
Depending on the definition used for sarcopenia, the prevalence in 60-70 year olds is 5-13%, 
while the prevalence ranges from 11- 50% in people 80 years or older (Morley 2008).  In 
addition, the prevalence of class I sarcopenia is approximately 52%, whereas the prevalence of 
class II is about 8% in individuals aged 60 and older.  The age-related loss of muscle mass and 
strength results in a decline in functional independence, physical disability, and mobility 
impairment (Janssen, Heymsfield et al. 2002).  Therefore, the sarcopenic older individual has 
greater difficulty doing basic activities of daily living, and an increased risk of falls and fractures.  
Loss of muscle mass is associated with a low threshold of fatigue (Fleg and Lakatta 1988) and a 
reduced resting metabolic rate (Lammes and Akner 2006).  Thus, individuals with sarcopenia 
have a reduced capacity for exercise and a decreased caloric requirement, which can further 
enhance the progression of sarcopenia.  Sarcopenia also contributes to the pathogenesis of 
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frailty, which is associated with increased hospitalizations, morbidity and mortality (Rolland, 
Czerwinski et al. 2008).  
The decrease in muscle mass that gives rise to sarcopenia involves both a decrease in 
muscle fiber size and number.  By the age of 70, the cross-sectional area of skeletal muscle can 
be reduced by up to 25-30% and muscle strength may be reduced by 30-40% (Porter, 
Vandervoort et al. 1995), with the loss of strength continuing to decrease at a rate of 1-2% per 
year (Skelton, Greig et al. 1994).  With aging, type II fibers atrophy more than type I fibers 
(Larsson, Sjodin et al. 1978) and the loss of lean body mass is greater in the lower body than in 
the upper body (Janssen, Heymsfield et al. 2000).  Although multiple lifestyle behaviors and 
mechanisms contribute to the development of sarcopenia, the loss of lean body mass is the 
result of differences in rates of protein breakdown and protein synthesis. 
Section 3.1: Decreased Anabolic Signaling 
The age related decrease in lean body mass may be a result of a combination of a 
decreased response to anabolic signaling and a reduction in anabolic stimuli.  The anabolic 
response of skeletal muscle proteins to essential amino acids, which are mainly responsible for 
the postprandial increase in muscle protein synthesis (Volpi, Kobayashi et al. 2003), is reduced in 
the elderly (Visser, Deeg et al. 2003). Skeletal muscle of older individuals is also resistant to the 
anabolic action of insulin (Rasmussen, Fujita et al. 2006).  Although the exact mechanism for the 
impaired response to both essential amino acids and insulin are not currently known, both 
appear to act through the mTOR pathway (Guillet, Prod'homme et al. 2004).  The mTOR 
pathway will be discussed in more detail in the nutrition, exercise and protein synthesis section 
of this review.  In the elderly, the blunted response to essential amino acids and insulin can 
result in reduced protein synthesis and therefore contribute to the reduction in lean body mass.   
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Aging is associated with several changes in hormonal levels, including a decrease in the 
concentrations of growth hormone (GH), insulin-like growth factor (IGF-1) and testosterone 
(Perrini, Laviola et al. 2010). Circulating GH levels decline after 30 years of age at a rate of 
approximately 1% per year, and as a result systemic IGF-1 concentrations also decline with 
advancing age (Hermann and Berger 2001).  In skeletal muscle, GH promotes the fusion of 
myogenic precursor cells into existing myotubules, and this requires IGF-1 (Perrini, Laviola et al. 
2010).  IGF-1 concentrations are positively correlated with muscle protein synthesis rates, 
specifically myofibrillar protein and myosin heavy chain synthesis (Waters, Baumgartner et al. 
2000).  A sustained decrease in these hormones is associated with decreased muscle size and 
strength, diminished protein synthesis and increased apoptosis (Perrini, Laviola et al. 2010).  
Although GH and IGF-1 are involved in muscle protein metabolism and maintenance, there is 
conflicting evidence whether replacement is effective in maintaining or gaining muscle mass 
(Onder, Della Vedova et al. 2009).  No effect on muscle strength, mass, or fiber size was 
observed following GH replacement (Lange, Andersen et al. 2002).  Conversely, an increase of 
muscle mass and strength was shown in older individuals after three months of GH treatment 
(Welle, Thornton et al. 1996).  The conflicting data involving the effectiveness of GH 
replacement may be the result of the duration of the treatment or dose, or it may be due to the 
extent of the initial GH deficiency.   
Testosterone decreases gradually at a rate of 1% per year and bioavailable testosterone 
by 2% per year in males after 30 years of age (Morley, Kaiser et al. 1997).  The overall reduction 
of testosterone is associated with loss of muscle strength and muscle mass (Mellstrom, Johnell 
et al. 2006).  Replacement of testosterone increases muscle mass and increases hypertrophy of 
both types I and II fibers by down-regulating myostatin (Kovacheva, Hikim et al. 2010), which 
regulates myogenesis through inhibition of satellite cell activation, proliferation, and 
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differentiation.  Additionally, testosterone decreases the age-related increase in oxidative stress 
and muscle cell apoptosis through suppression of c-jun NH2-terminal kinase and p21, 
respectively (Kovacheva, Hikim et al. 2010).  However, there is conflicting research regarding 
testosterone’s effect on muscle mass and strength gains following resistance exercise.  Young 
men exposed to either basal testosterone concentrations or high testosterone concentrations 
experienced similar increases in muscle strength and muscle cross sectional area (West, Burd et 
al. 2010).  Similarly, in post-menopausal women, there is conflicting evidence that hormone 
replacement therapy affects muscle mass and strength (Onder, Della Vedova et al. 2009).  In 
older men and women, long term (1 year) treatment with either dehydroepiandrosterone 
(DHEA) or testosterone did not result in an increase in whole body or muscle protein synthesis 
(Henderson, Dhatariya et al. 2009).    
Age related changes in neuromuscular signaling may also contribute to the loss of 
muscle mass.  The number of α-motor neurons declines with age (Brown 1972), resulting in 
denervation of the muscle fibers within the motor unit.  This denervation causes the muscle 
fibers to atrophy, which leads to a decrease in muscle mass.  However, the decline in α-motor 
neurons is minor (only 10-15%), and therefore may not account for all deficits in neuromuscular 
signaling (Ulfhake, Bergman et al. 2000).  Oxidative stress may also cause phenotypic changes in 
the motor neuron, which can interfere with neurotransmission and contribute to 
neurodegeneration (Ramirez-Leon, Kullberg et al. 1999).  Overall, decreases in anabolic signaling 
and anabolic stimuli may result in decreased lean body mass in older individuals. 
Section 3.2: Oxidative Stress    
Oxidative stress has been implicated as a central mechanism in the pathogenesis of 
sarcopenia (Semba, Lauretani et al. 2007).  A significant age-dependent increase in oxidative 
damage to protein, lipids, and DNA occurs in skeletal muscle (Mecocci, Fano et al. 1999).  
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Oxidative stress can be the result of either a reduction in the antioxidant capacity or an increase 
in the production of reactive oxygen species (ROS), which is a byproduct of the electron 
transport chain within mitochondria (Fulle, Protasi et al. 2004).  ROS activates nuclear factor-
kappa B (NF-κB), which contributes to the loss of skeletal muscle mass (Li, Malhotra et al. 2008) 
through the following pathways: 1) NF-κB increases the expression of MuRF1 E3 ubiquitin ligase 
and other proteins in the ubiquitin proteasome, which leads to the degradation of skeletal 
muscle; 2) NF-κB induces muscle wasting by preventing myofilament protein synthesis and their 
organization into myofilament by down regulating MyoD; and 3) NF-κB also increases the 
expression of inflammatory cytokines, including tumor necrosis factor-α (TNF-α), and interleukin 
1 (IL1) and interleukin 6 (IL6) (Li, Malhotra et al. 2008).  Proinflammatory cytokines (TNF-α, IL1 
and IL6) promote muscle wasting directly by increasing myofibrillar protein degradation (Fong, 
Moldawer et al. 1989) and by decreasing protein synthesis (Lang, Frost et al. 2002).  
Furthermore, TNF-α induces expression of metalloproteinase-9 (MMP-9), a protease that 
degrades several components of extracellular matrix-cytoskeleton linkage in skeletal muscle (Li, 
Malhotra et al. 2008).  Although oxidative stress contributes to protein breakdown, protein 
breakdown does not significantly increase with aging (Volpi, Sheffield-Moore et al. 2001); 
therefore, impaired protein synthesis would be expected to be responsible for the loss of 
muscle mass over time.   
Within skeletal muscle, oxidative damage to mitochondrial DNA (mtDNA) contributes to 
sarcopenia.  The mitochondria genome is especially susceptible to oxidative DNA damage due to 
multiple factors, including: 1) exposure of mtDNA to ROS as mtDNA are in close proximity to the 
electron transport chain (ETC), where complexes I and III are the predominant site for ROS 
production; 2) the lack of protective histones; 3) the lack of introns results in densely packed 
genetic information, so that damage will likely occur within a gene; and 4) a relative lack of DNA 
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repair enzymes (compared to nuclear DNA)  (Hiona and Leeuwenburgh 2008).  The ROS induced 
damage to the mtDNA gives rise to both mtDNA mutations and deletions that accumulate 
progressively during aging.  The increased accumulation of mtDNA mutations is responsible for 
the observed decreases in the activities of complexes III and IV of the respiratory chain and the 
concomitant increase in complex II in older individuals (Chabi, Mousson de Camaret et al. 2005).  
The increase in complex II activity leads to a competition with complex I for the use of the 
quinone pool resulting in a reduced ability of complex I to oxidize NADH, which leads to 
mitochondria dysfunction, decreased energy production and muscle fiber atrophy (Cao, 
Wanagat et al. 2001).  In the mitochondrial theory of aging, mitochondrial dysfunction leads to 
an even greater increase in ROS production, which results in further increases in oxidative stress 
and thus an increased rate of mtDNA damage and mutations (Hiona and Leeuwenburgh 2008).  
Mitochondrial dysfunction also impairs ATP production (Shigenaga, Hagen et al. 1994), which 
contributes to fatigue in older individuals.  Furthermore, decreased efficiency of ATP production 
may result in a decrease in energetically costly processes such as protein synthesis (Dirks, Hofer 
et al. 2006).  The overall effects of oxidative stress in skeletal muscle may lead to mitochondrial 
dysfunction, decreased protein synthesis and increased protein degradation, thus leading to 
reduced skeletal muscle mass and wasting.    
Section 3.3: Lifestyle Behaviors 
 Decreased physical activity may contribute to sarcopenia and wasting.  Few older adults 
achieve the minimum recommended 30 or more minutes of moderate physical activity on five 
or more days per week.  Data from the Centers for Disease Control and Prevention indicate that 
about 28-34% of adults aged 65 to 74 and 35-44% of adults ages 75 or older are inactive.  
Additionally, few older individuals engage in regular physical activity.  Only 31% of individuals 
aged 65 to 74 reports participating in 20 minutes of moderate physical activity three or more 
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days per week, and only 16% report 30 minutes of moderate activity five or more days per 
week.  For those aged 75 and older, levels of activity are even lower: 23% engage in moderate 
activity for 20 minutes three or more days per week and only 12% participate in such activity for 
30 minutes five or more days per week.  Exercise training could improve the ability of older 
individuals to remain functional and independent.  Exercise can increase skeletal muscle size and 
strength (Charette, McEvoy et al. 1991), and can result in increases in whole body (Tarnopolsky, 
Atkinson et al. 1991) and muscle protein synthesis (Chesley, MacDougall et al. 1992).  An 8-week 
training program (cycling exercise) in older persons can increase total energy expenditure by 
elevating resting metabolic rate, with up to a 12% increase in energy intake (Poehlman and 
Danforth 1991).  A single bout of resistance exercise can increase ghrelin, an appetite stimulant, 
which can remain elevated 24 hours after exercise (Ghanbari-Niaki 2006).  Therefore, exercise 
can increase both protein synthesis and food intake in older individuals.   
The age associated physiologic reduction in food intake, which has been termed "the 
anorexia of aging", contributes to the low dietary energy intake that is common among healthy 
elderly adults (Fujita and Volpi 2004).  Approximately 30% of older individuals consume the 
recommended dietary allowance (RDA) or less (McDowell, Briefel et al. 1994).  Both 
physiological and nonphysiological causes result in this reduced consumption of food (and thus 
calories) with aging.  The major physiological change that influences food intake is a loss of 
appetite.  A number of factors are known to contribute to the decrease in appetite of older 
individuals including a decline in olfaction and gustaoception (Kaneda, Maeshima et al. 2000).  
These changes act together to decrease the perception of the hedonic qualities of food resulting 
in decreased enjoyment of food (Morley 2001) and a subsequent change in food preferences 
with an increased predilection for sweet, protein-poor foods (Morley 1997).  Early satiation in 
older individuals also contributes to decreased food intake.  When older individuals received the 
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same amount of food as younger persons they reported greater satiation (Clarkston, Pantano et 
al. 1997).  Increased circulating cholecystokinin (CCK) and decreased rate of gastric emptying 
both contribute to this increased perceived satiation.  Dementia, poor oral health, and 
swallowing disorders can also contribute to the decreased food intake (Morley 1997).  
Nonphysiological changes associated with aging also influence food intake.  Many elderly 
experience social isolation caused either by living alone or due to the lack of social relationships 
and this social isolation may lead to reduced food consumption (McIntosh, Shifflett et al. 1989).  
Depression is more common in older individuals and approximately 90% of older individuals 
with depression lose weight compared to 60% in younger people with depression (Sheiham, 
Steele et al. 2001).  The side effects of drugs are a major cause of weight loss in older 
individuals, as certain drugs are known to cause malabsorption and decrease appetite (Morley 
1997).  With the decrease in total food intake, older individuals are less likely to consume 
adequate vitamins and nutrients.  In older individuals, vitamin D deficiency is associated with 
muscle weakness and sarcopenia (Visser, Deeg et al. 2003) and any vitamin deficiency may 
cause a reduction in defense mechanisms against free radicals, thus increasing oxidative stress 
(Weindruch 1995).  In older individuals, various age related factors contribute to decreased food 
intake and negative energy balance. 
Section 4: Nitrogen Balance 
 Nitrogen balance is commonly used to measure whole body protein balance.  Protein is 
the major nitrogen-containing substance within the body, and a gain or loss of nitrogen can be 
considered as synonymous with a gain or loss of protein (Calloway and Spector 1954).  When 
nitrogen intake exceeds the amount of nitrogen excreted, an individual is in positive nitrogen 
balance.  Protein (nitrogen) intake that is less than the amount of nitrogen excreted results in a 
state of negative nitrogen balance and when protein intake is equal to the amount excreted, an 
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individual is in nitrogen balance.  Nitrogen balance can be determined through the following 
equation:   
Nitrogen balance (g) = Nitrogen intake – nitrogen output 
Nitrogen intake is calculated from the amount of protein consumed, with 6.25 grams of protein 
equivalent to approximately one gram of nitrogen (Thomas, Bishop et al. 2007).  Nitrogen 
output is defined as the nitrogen excreted in urine and feces plus miscellaneous nitrogen losses 
(Calloway, Odell et al. 1971).  On average, 2 g/day of nitrogen is excreted in the feces and 
approximately 5 mg/kg body weight (bw)/day of nitrogen is lost through miscellaneous routes 
including sweat, hair, nails, and skin cells (Calloway, Odell et al. 1971).  
The body disposes of nitrogen by converting ammonia to urea ((NH2)2CO) through the 
urea cycle.  Approximately 80% of excreted nitrogen is excreted as urea (Thomas, Bishop et al. 
2007).  In the liver, amino groups are transferred in transaminase reactions to glutamate.  The 
glutamate can then be oxidized through the glutamate dehydrogenase reaction, forming α-
ketoglutarate and an ammonium ion (NH4
+).  The NH4
+ is subsequently involved in the initial step 
of the urea cycle.  The urea cycle begins with two mitochondrial reactions: 1) the condensation 
of NH4
+ and carbon dioxide (CO2) via carbamoyl phosphate synthetase to form carbamoyl 
phosphate and 2) condensation of carbamoyl phosphate with ornithine to form citrulline.  
Citrulline is then exported from the mitochondria and combines with aspartic acid to form 
arginosuccinate via the cytoplasmic arginosuccinate synthetase reaction.   Arginosuccinate is 
then hydrolyzed to form fumarate and arginine.  The cycle is completed when arginase cleaves 
arginine to form urea, which is then released into the blood and transported to the kidney for 
excretion (Storey 2004).  The urea cycle is a vital process for eliminating nitrogen, as excess 
nitrogen in the body is highly toxic to the central nervous system (Roach and Benyon 2003). 
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Although nitrogen balance is commonly utilized to assess whole body protein turnover, 
there are limitations associated with the nitrogen balance technique.  Nitrogen balance does not 
indicate whether a change in protein balance is a result of a change in protein synthesis or 
protein breakdown, or a combination of both.  Additionally, changes in protein metabolism 
within individual tissues such as skeletal muscle can not be determined using the nitrogen 
balance technique.  Inflated nitrogen retention is another limitation of the nitrogen balance 
technique (Kopple 1987).  Nitrogen intake can be overestimated if any food is not completely 
consumed.  Furthermore, nitrogen intake is estimated based on total protein intake, with 6.25 
grams of protein containing 1 gram of nitrogen.  However, 6.25 grams of protein do not always 
contain 1 gram of nitrogen, as 6.25 is an average based on protein quality.  Inadequate 
collection of any excreted nitrogen can also contribute to the overestimated nitrogen retention.  
Collecting miscellaneous nitrogen losses can be quite challenging, and therefore relies on 
estimates.  Thus, variability between individuals could contribute to the overestimated nitrogen 
balance.  Finally, nitrogen balance requires a time period of approximately five to eight days for 
an individual to adjust to a change in total protein consumption(WHO 2007); therefore a short 
term controlled diet is required before nitrogen balance studies to allow an individual to adapt 
to a new protein intake (Rand, Young et al. 1976).  However, recent research indicates that 
acute changes in protein intake (±4% of habitual protein intake) does not result in changes in 
whole body proteolysis or muscle protein synthesis (Yarasheski, Castaneda-Sceppa et al. 2011).  
Thus, a short term controlled diet may not be necessary for individuals to adapt to an acute 
change in protein intake.        
Despite limitations, the nitrogen balance technique can be a useful technique for 
studying whole body protein turnover in aging populations.  The contribution of muscle protein 
to whole body protein metabolism is significantly reduced in the elderly.  Consequently, the 
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contribution of non skeletal muscle protein, especially visceral tissue whose rates of protein 
turnover are known to be more rapid, is proportionally greater with aging (Morais, Chevalier et 
al. 2006).  Thus, the nitrogen balance technique with its noninvasive nature makes it a relatively 
easy and appropriate method to determine long term changes in whole body protein turnover 
in response to exercise and nutrition interventions in older individuals. 
Section 4.1: Nutrition and Nitrogen Balance 
 Similar to protein synthesis, which was previously discussed, nitrogen balance is also 
affected by energy and protein intake.  Nitrogen balance is better maintained when caloric 
intake is adequate, as a negative nitrogen balance results when energy intake is reduced by 15% 
(Todd, Butterfield et al. 1984).  In addition, an individual in negative energy balance may 
decrease their physical activity to compensate for the inadequate caloric intake (Gorsky and 
Calloway 1983), which can further contribute to wasting.  During caloric restriction, protein 
breakdown increases the availability of amino acids that are oxidized as energy and thus limits 
the availability of amino acids for protein synthesis.  Increasing energy intake can result in a 
more positive nitrogen balance (Calloway and Spector 1954) as amino acids are utilized less for 
energy and are therefore available for protein synthesis.  When energy intake is reduced, 
increased protein intake can enhance nitrogen retention (Calloway and Spector 1954).  Older 
women in negative energy balance maintain more lean body mass when protein intake is 
increased from 0.8 g/kg bw to 1.6 g/kg bw per day (Layman, Boileau et al. 2003).  Similarly, 
elderly women in energy balance maintain a significantly greater nitrogen balance when a high 
protein diet (0.92 g/kg bw per day) is consumed compared to a low protein diet (0.45 g/kg bw 
per day).  Furthermore, the low protein diet also resulted in a significant loss of lean body mass, 
muscle function and immune function (Castaneda, Charnley et al. 1995).  Inadequate protein 
intake limits the availability of amino acids for protein synthesis and thus a negative nitrogen 
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balance results.  When caloric intake is adequate, protein intake significantly above the RDA 
does not result in significant increases in nitrogen balance (Calloway and Spector 1954) as 
excess nitrogen is excreted via the urea cycle.  In general, total energy intake required to 
maintain nitrogen balance decreases as protein consumption increases.   
Section 4.2: Exercise and Nitrogen Balance 
Both aerobic and resistance exercise can result in a more positive nitrogen balance by 
increasing nitrogen retention.  If energy balance is maintained, one hour of aerobic exercise can 
significantly increase nitrogen balance and spare approximately 2.5 mg/kg bw of nitrogen (Todd, 
Butterfield et al. 1984).  Aerobic exercise can also increase nitrogen balance when caloric intake 
is inadequate, but the increase is less pronounced compared to when energy balance is 
maintained (Todd, Butterfield et al. 1984).  However, nitrogen balance is better maintained 
during a 15% negative energy balance when the energy deficit is a result of exercise, rather than 
a reduction in caloric intake (Todd, Butterfield et al. 1984).  Similar to aerobic exercise, 
resistance exercise can also result in a more positive nitrogen balance.  When older adults in a 
12 week resistance exercise program consumed a negative energy balance diet that provided 
either 0.8 g/kg bw  (low protein) or 1.6 g/kg bw (high protein) of protein, individuals on the high 
protein diet retained more nitrogen than the low protein diet (Campbell, Crim et al. 1995).  
Although exercise can compensate (to a point) for inadequate energy and protein intake, 
nitrogen retention is better maintained when both energy and protein intake are adequate. 
Section 5: Nutrition, Exercise, and Protein Synthesis 
Section 5.1: mTOR Regulates Protein Synthesis 
 mTOR is a nutrient and energy-sensing protein that regulates protein synthesis.  mTOR 
stimulates protein synthesis mainly through three downstream effectors that are involved in 
protein translation, including: eukaryotic initiation factor 4E-binding protein 1 (4E-BP1), p70 
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ribosomal S6 kinase (p70s6k), and eukaryotic initiation factor 4G (eIF4G) (Raught, Gingras et al. 
2001).  mTOR controls various components involved in the initiation and elongation stages of 
translation, both of which are implicated as the rate limiting step in protein synthesis under 
conditions of fasting (Rannels, Pegg et al. 1978) and feeding (Morgan, Jefferson et al. 1971), 
respectively.  When 4E-BP1 is phosphorylated, eIF4E is released and can then form the eIF4F 
complex together with eIF4G.  The assembly of this complex is necessary for translation 
initiation (Raught, Gingras et al. 2001).  p70s6k increases the activity of eEF2, which mediates the 
translocation during the elongation phase of translation (Browne, Finn et al. 2004).  Although 
the mechanism by which mTOR activates its effectors is not fully understood, mTOR could 
stimulate 4E-BP1, eIF4G, and p70s6k either by direct phosphorylation, indirectly by activating 
another protein kinase (Raught, Gingras et al. 2001), or by inhibiting a phosphatase (Li, 
Corradetti et al. 2004).   
 Energy status can regulate the rate of protein synthesis through mTOR signaling.  AMPK 
functions as a sensor of energy status, which can then mediate its effects through mTOR. 
(Miyazaki and Esser 2009).  AMPK is regulated by changes in the AMP to ATP ratio, such that an 
increase in the AMP to ATP ratio stimulates AMPK.  Activated AMPK phosphorylates tuberous 
sclerosis complex 2 (TSC2) and thus enhances its inhibitory function leading to decreased mTOR 
activity (Inoki, Zhu et al. 2003).  In energy deprived conditions, further phosphorylation by 
glycogen synthase kinase 3 (GSK-3) on multiple residues of TSC2 leads to further inhibition of 
mTOR activity (Inoki, Ouyang et al. 2006).  During times of energy surplus, such as feeding, 
mTOR can stimulate protein synthesis in response to insulin.  Insulin stimulates protein synthesis 
by activating the insulin signaling pathway leading to an increase in phosphoinositide 3-kinase 
(PI3K) and Akt/PKB (protein kinase B) activity.  Akt/PKB phosphorylates and inhibits the TSC2, 
thus allowing ras homolog enriched in brain (Rheb) to accumulate in its active GTP-bound form, 
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which acts to stimulate mTOR and increases protein synthesis (Avruch, Hara et al. 2006).  
Meanwhile, during an energy surplus, the ratio of AMP to ATP decreases and the AMPK 
inhibition of mTOR decreases, allowing for further stimulation of mTOR and protein synthesis.   
  mTOR is regulated by the availability of amino acids.  Amino acid deprivation leads to 
decreased mTOR signaling and decreased rates of protein synthesis.  The decreased mTOR 
signaling is reversed within minutes by the re-addition of amino acids (Hara, Yonezawa et al. 
1998).  Essential amino acids alone can stimulate protein synthesis, with leucine having the most 
potent effect (Anthony, Yoshizawa et al. 2000).  The mechanism by which amino acids regulate 
mTOR signaling is not currently known, although it is believed that the amino acids can inhibit 
an upstream phosphatase, stimulate a kinase, interact with various upstream proteins that act 
on mTOR or amino acids can directly activate mTOR (Deldicque, Theisen et al. 2005).  Amino 
acids are required for translation, and therefore when amino acid availability is low, mTOR 
signaling decreases and consequently protein synthesis is also decreased.     
Exercise can also enhance protein synthesis through the mTOR pathway.  The 
mechanism of mTOR activation is unclear, but it is believed to occur through activation of PKB or 
through direct phosphorylation of mTOR (Deldicque, Theisen et al. 2005).  Exercise induced 
p70s6k activity is strongly correlated with increased skeletal muscle mass after six weeks of 
resistance training (Baar and Esser 1999).  Additionally, nutrition can take advantage of the 
anabolic period triggered by exercise.  Consumption of a branched chain amino acid beverage 
during exercise significantly increases phosphorylation (and thus activation) of mTOR (Liu, Jahn 
et al. 2001; Karlsson, Nilsson et al. 2004).  mTOR regulates protein synthesis in response to 





Section 5.2: Timing of Intake 
 The timing of nutrient intake relative to exercise is important to enhance protein 
synthesis.   A mixed nutrient supplement taken immediately after one hour of moderate-
intensity aerobic exercise results in a greater increase in whole body protein synthesis compared 
to ingestion three hours after exercise (Levenhagen, Gresham et al. 2001).  Similarly, older 
individuals in a 12-week resistance training program had greater increases in skeletal muscle 
cross sectional area and strength when a mixed nutrient supplement was consumed 
immediately after resistance exercise compared to two hours after exercise (Esmarck, Andersen 
et al. 2001).  In another study, young female athletes in exercise-induced negative energy 
balance consumed either a mixed-meal beverage or a non-caloric placebo beverage after 
exercise.  Diet was replicated between the two trials, so that the timing of intake was the only 
difference between the trials.  Although nitrogen balance was not significantly greater when the 
mixed-meal beverage was consumed post-exercise, there was a strong trend (p=0.06) for an 
increase in nitrogen balanced when the mixed-meal beverage was consumed post-exercise (Roy, 
Luttmer et al. 2002).  Moreover, when older individuals in energy balance consumed a chocolate 
milk beverage immediately after one hour of aerobic exercise rather than earlier in the day, a 
more positive nitrogen balance was maintained (Jordan, Melanson et al. 2010).  However, there 
is conflicting data about the effect of timing of feeding.  An amino acid-carbohydrate drink 
consumed one or three hours after resistance exercise had similar increases in muscle protein 
synthesis (Rasmussen, Tipton et al. 2000).  Furthermore, the response of net muscle protein 
synthesis to consumption of an amino acid-carbohydrate solution immediately prior to 
resistance exercise is greater compared to after exercise (Tipton, Rasmussen et al. 2001).  Yet, in 
another study, an amino acid-carbohydrate supplement ingested before resistance exercise did 
not enhance post-exercise muscle protein synthesis compared to exercise without added 
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nutrients (Fujita, Dreyer et al. 2009).  Since nitrogen balance is closely related to energy balance 
(Todd, Butterfield et al. 1984), the conflicting data regarding timing of nutrient intake may be 
due to differences in energy balance.  Despite conflicting research, consuming protein 
immediately after exercise, while in energy balance, appears to be most effective for enhancing 
protein synthesis.    
Section 5.3: Protein Quality 
 The quality of proteins consumed after exercise can affect protein synthesis.  Protein 
quality depends on both the amino acid composition and the digestibility of the proteins.  A high 
quality protein, also known as a complete protein, contains adequate amounts of all essential 
amino acids, whereas an incomplete protein, or low quality protein is lacking in one or more 
essential amino acids.  Sources of complete proteins are mostly foods derived from animal 
origin such as milk and meat, while incomplete proteins are usually derived from plant foods 
including vegetables, legumes and grains (Gropper, Smith et al. 2009).  In elderly women, 
consuming a high-protein meal from an animal source, compared to a high-protein meal from 
non-animal sources, resulted in a significant increase in net protein synthesis, which over time 
could result in maintenance of lean body mass (Pannemans, Wagenmakers et al. 1998).  
Similarly, consumption of milk-based proteins resulted in a positive net protein balance and an 
increased rate of muscle protein synthesis after resistance exercise compared to soy-based 
proteins (Wilkinson, Tarnopolsky et al. 2007).  The difference in the metabolism of milk and soy 
proteins is due to the rate of digestion (Bos, Metges et al. 2003).  The rate of digestion and 
absorption of dietary amino acids varies according to the type of ingested dietary protein.  For 
example, milk consists of both whey and casein proteins (Jenness 1979), whereas soy contains a 
single protein fraction that is digested similar to whey protein (Bos, Metges et al. 2003).  Whey 
protein, which is considered a “fast” protein, is rapidly digested, and the amino acids are quickly 
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absorbed resulting in rapid appearance of amino acids in the plasma.  The rapid increase in 
plasma amino acids results in an acute increase in protein synthesis (Boirie, Dangin et al. 1997).  
Conversely, casein protein, which is considered a “slow” protein, is digested more slowly, and 
the plasma appearance of amino acids is slower and more prolonged.  Ingestion of casein 
proteins results in a minor increase in protein synthesis and a significant decrease in protein 
breakdown (Boirie, Dangin et al. 1997).  In young men at rest, muscle protein synthesis was 93% 
greater after consumption of whey compared to casein and 18% greater than soy.  Furthermore, 
following resistance exercise muscle protein synthesis was 122% greater after consumption of 
whey compared to casein and 31% greater than soy (Tang, Moore et al. 2009).  Consumption of 
milk, which consists of both whey and casein proteins, could maximize net protein accretion by 
stimulating protein synthesis and reducing protein breakdown.   
In general, compared to lower quality proteins, high quality proteins such as milk have 
increased essential amino acid content and in particular, increased leucine content.  Leucine is a 
potent stimulator of protein synthesis and can stimulate protein synthesis in muscle 
independent of other amino acids (Buse and Reid 1975) or insulin (Anthony, Reiter et al. 2002).  
Leucine stimulates protein synthesis by enhancing translation initiation through the mTOR 
pathway by down-regulating the translational repressor 4E-BP1 (Anthony, Anthony et al. 2000) 
and up-regulating p70s6k (Burnett, Barrow et al. 1998).  Consumption of a leucine-rich 
supplement after exercise resulted in a significant increase in muscle protein synthesis 
compared to both a carbohydrate only supplement and a carbohydrate with added protein 
supplement (Koopman, Wagenmakers et al. 2005).  Thus, consuming high quality proteins with 





Section 5.4: Management of Wasting with Exercise and Nutrition 
 Exercise and nutrition represent two strategies to maintain lean body mass and prevent 
wasting.  Older men in a 12-week resistance training program increased muscle cross sectional 
area more than 11% and improved leg extensor and flexor strength by 107% and 226%, 
respectively (Frontera, Meredith et al. 1988).  Similarly, older women in a 12-week aerobic 
training program increased whole muscle volume by 12% and increased leg extensor strength by 
55% (Harber, Konopka et al. 2009).  Therefore, aerobic and resistance exercise can increase both 
strength and lean body mass in older individuals.  Timing nutritional intake after exercise can 
further enhance the beneficial effects of exercise.  When older individuals consumed a 
chocolate milk beverage immediately after one hour of aerobic exercise rather than earlier in 
the day, a more positive nitrogen balance was maintained (Jordan, Melanson et al. 2010).  In 
addition, when nutrition is combined with exercise, muscle protein synthesis can remain 
elevated for up to 72 hours after exercise (Miller, Olesen et al. 2005).  Thus, exercise followed by 
a high quality protein source could further enhance protein synthesis and lean body mass more 
than exercise or nutrition alone.  
In addition to increased muscle size and strength, exercise can also increase appetite 
and enhance total caloric intake (Ghanbari-Niaki 2006).  By increasing appetite and energy 
intake, older individuals are more likely to consume adequate vitamins and nutrients, and 
remain in energy balance.  Energy balance is important for maintaining lean body mass as 
negative energy balance results in a more negative nitrogen balance, and therefore a reduction 
in whole body protein synthesis (Hoffer, Bistrian et al. 1984; Todd, Butterfield et al. 1984).  
Adequate intake of vitamins is essential for preventing sarcopenia, as any vitamin deficiency 
may cause a reduction in defense mechanisms against free radicals, which increases oxidative 
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stress (Weindruch 1995).  As discussed previously, oxidative stress is a central mechanism in the 
pathogenesis of sarcopenia.     
Protein intake above the RDA (0.8 g/kg bw) may be another approach to prevent 
sarcopenia and wasting.  In elderly women, protein intake below the RDA is associated with 
significant losses of muscle mass and muscle strength (Castaneda, Charnley et al. 1995), 
however  almost 40% of individuals over the age of 70 do not consume the RDA for protein 
(Houston, Nicklas et al. 2008).  A study by Campbell et al. demonstrated that even when older 
individuals in energy balance consume the RDA for protein, negative nitrogen balance and loss 
of mid-thigh muscle area results (Campbell, Trappe et al. 2001), which indicates that protein 
intake above the RDA may be necessary to maintain nitrogen balance.  However, recent 
research from their lab indicates that the current RDA for protein intake is adequate for older 
individuals to maintain nitrogen balance (Campbell, Johnson et al. 2008).  Despite early research 
indicating that the RDA for protein intake may be inadequate, recent research indicates that the 
current RDA for protein is adequate for older individuals to maintain nitrogen balance. 
The age related decrease in muscle mass and function is common as individuals’ age.  
Sarcopenia is a multifactorial process that is associated with a retraction of anabolic signaling 
and an increase in catabolic stimuli.  Although multiple lifestyle behaviors and mechanisms 
contribute to the development of sarcopenia, the loss of lean body mass is the result of 
differences in rates of protein breakdown and protein synthesis.  Over time, if protein 
breakdown exceeds protein synthesis, loss of lean body mass will occur.  Sarcopenia is a gradual 
process, so any intervention that slightly increases nitrogen balance and thus protein synthesis 
may be adequate to prevent or reduce the loss of lean body mass.  Overall, few strategies exist 
to prevent or treat sarcopenia, but nutrition and exercise interventions appear to be ideal for 
managing sarcopenia.  Our lab previously showed that timing protein intake after aerobic 
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exercise versus earlier in the day, can increase nitrogen balance in older individuals in energy 
balance.  Since caloric deficiencies are common in older individuals, this study aims to 
investigate whether protein consumption after exercise, rather than earlier in the day, can 
increase nitrogen balance in older individuals in negative energy balance. 























METHODS AND PROCEDURES 
 
Study Overview 
The current study investigated whether consumption of protein immediately after one 
hour of moderate aerobic exercise, compared to earlier in the day, can improve nitrogen 
balance in older individuals in negative energy balance.  The study included four separate 
phases, which included: pre-experimental testing, a seven-day lead in diet, a six-day 
experimental phase, and a one-day post-testing period (Figure 3.1). 
Figure 3.1 Study timeline   
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 During the pre-testing phase of the study, data was collected that was used for the 
planning of the diets (lead-in and inpatient diets) and to determine the relative intensity of the 
daily aerobic exercise during the inpatient phase.  The seven-day lead-in diet allowed subjects to 
adapt to the level of protein that subjects were exposed to during the inpatient phase of the 
study. 
 The inpatient phase of the study consisted of a 6-day inpatient stay at the University of 
Colorado Denver Clinical and Translational Research Center (CTRC).  Subjects completed two, 
three-day trials in a randomized cross-over design (CHO and PRO+CHO).  Subjects stayed one 
day during each three-day trial (inpatient Day 1 and Day 6) in a whole room calorimeter to 
confirm that subjects were in 15% negative energy balance (see Figure 3.2). 
Figure 3.2 Inpatient phase 
 
Subjects stayed in a hospital room in the CTRC during days two through five, where they 
were permitted to leave twice a day for 30 minutes.  For the duration of the stay, breakfast, 
lunch, and dinner were delivered at the same specific time each day.  One hour of cycling 
exercise was performed each day from 16:30 until 17:30.  Immediately following the exercise, 
subjects consumed their post-exercise beverage.  During the PRO+CHO condition, subjects 
consumed a chocolate milk beverage immediately following the exercise and during the CHO 
condition, a carbohydrate beverage was consumed immediately post-exercise.  The diets for 







each three-day condition were isocaloric and isonitrogenous.  In addition, the foods consumed 
during each condition were identical and consumed at similar times for each condition.  Only the 
timing of the protein-containing beverage differed between the two conditions.  The study 
protocol was approved by the Colorado State University Institutional Review Board and the 
Colorado Multiple Institutional Review Board for human participants’ research.    
Figure 3.3 Timing of meals and beverages during inpatient phase 
 
Participants 
 Ten male (n=2) and female (n=8) subjects between 55 and 75 years old were recruited 
for the study from the Fort Collins and Loveland Colorado area.  For inclusion, individuals were 
required to be non-smoking, inactive, lactose tolerant, and not taking any medications.  Other 
exclusion criteria included: obesity (BMI > 30), any orthopedic injury that would impede their 
ability to exercise, any condition that affected food digestion or digestion, a thyroid condition 
(TSH <0.05uU/mL or TSH>5.0uU/mL), a bleeding disorder, or any current illness or infection.  See 






































Table 3.1 Participant characteristics 
 Male (n=2) Female (n=8)  All subjects (n=10) 
 Mean ±SE Mean ±SE Mean ±SE 
Age 67.0±1.0 63±1.8 63.8±1.7 
Height (cm) 183.4±1.0 165.3±2.4 168.9±3.2 
Weight (kg) 92.2±1.0 60.9±1.7 67.2±4.4 
BMI (kg/m2) 27.4±0.3 22.3±0.6 23.6±0.8 
Body fat (%) 27.9±1.0 34.5±1.7 33.2±1.7 
VO2max (ml·kg
-1·min-1) 32.2±0.5 28.5±1.7 29.2±1.4 
 
Screening 
The initial screening visit was conducted at the Human Performance Clinical/Research 
Laboratory (HPCRL) at Colorado State University.  During the screening visit, subjects completed 
an informed consent, a HIPAA-B Approval form, and a medical and exercise history 
questionnaire (Appendices I, II, and III).  In addition, an online food preference and food allergy 
questionnaire from the CTRC was completed and three-day diet logs were given to the subjects.  
Subjects were instructed to return their completed three-day diet logs at their first pre-testing 
appointment.  All foods from three-day diet records were entered into Nutrition Pro software 
(Axxya Systems, Stafford, TX) and analyzed to determine habitual (free-living) energy and 
macronutrient intake.  In addition, subjects also had a blood draw at Poudre Valley Hospital 
prior to their initial pre-testing visit to ensure that thyroid stimulating hormone concentrations 
were within 0.05uU/mL to 5.0uU/mL.   
Pre-Testing 
 Over four separate days, subjects completed a series of pre-testing at the HPCRL.  
During the initial visit, subjects completed a graded exercise test (GXT) on a treadmill.  The test 
began with subjects walking at 3.3 miles per hour with a 0.0% grade.  The treadmill speed 
remained at 3.3 miles per hour for the duration of the test, but the grade increased by 2% after 
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the first minute and by 1% every minute after the first minute.  During the test, heart rate, 
rating of perceived effort, blood pressure, and an electrocardiograph (EKG) was recorded every 
three minutes.  The test was ended when subjects reached 85-100% of their predicted 
maximum heart rate (220-age) or when the subjects were too fatigued to continue.  The GXT 
was supervised by a cardiologist and subjects were excluded if the tests indicated an ischemic or 
hypertensive response to the exercise. 
 On a different day subjects returned to the HPCRL after an overnight fast.  Resting 
metabolic rate (RMR) (Parvomedics TrueOne 2400, Sandy, UT) was measured to determine 24-
hour resting caloric expenditure.  During the test, subjects rested in the supine position with the 
lights dimmed and all expired gases were collected.  Subjects were instructed to remain still and 
to refrain from sleeping.  The flow rate was adjusted to maintain FECO2 levels between 0.9-1.0%.  
The first 15 minutes of the test was used to achieve the appropriate flow rate and to allow the 
subjects to become familiarized with the experimental conditions.  The data from the final 30 
minutes of the test was used to predict RMR.  The values for daily energy expenditure were 
averaged and any measurement outside of ±2 standard deviations was omitted.  After the RMR 
test was completed subjects underwent a dual-energy X-ray absorptiometry (DEXA) scan (QDR 
4500W, Hologic, Inc., Bedford MA) to determine body composition.    
 On the third day of testing subjects completed an incremental exercise test on a cycle 
ergometer (Monark Excalibur, Groningen, The Netherlands) with indirect calorimetry 
(Parvomedics TrueOne 2400, Sandy, UT) to determine VO2max.  Subjects pedaled at 50 Watts for 
the first minute, and Watts increased by 20 for females and 30 for males every two minutes 
thereafter.  Throughout the test, subjects maintained a pedal rate between 70-90 rpm’s.  The 
test was stopped when subjects reached volitional exhaustion.  Subjects were considered to 
have reached volitional exhaustion when VO2 reached a plateau (less than 2mL per kg per min 
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increase) or when heart rate was within 10 beats of predicted maximum heart rate and 
respiratory exchange ratio (RER) was greater than 1.1.  After VO2max was determined, 55% of 
each subject’s VO2max was calculated.  Equation 3.1 was used to estimate the cycle ergometer 
rate that would correspond to a steady-state exercise intensity of 55% of VO2max.   
Equation 3.1 ACSM leg cycle ergometry equation 
VO2 (ml∙kg
-1∙min-1) = 1.8 (work rate)/ (BM)* + resting VO2 (3.5 ml∙kg
-1∙min-1) + unloaded 
cycling (3.5 ml∙kg-1∙min-1) 
*work rate=kg∙m∙min-1 and BM=body mass (kg) 
 On another day subjects returned to the HPCRL for a submaximal steady-state cycling 
test.  Subjects began cycling at their estimated workload (from equation 3.1) and once VO2 
stabilized they continued cycling for an additional 30 minutes.  Through indirect calorimetry, 
energy expenditure was determined by averaging the energy expenditure from the final 30 
minutes of cycling.  The calculated energy expenditure from the 30 minutes of cycling was used 
to estimate the subject’s energy expenditure during the one hour of cycling during the inpatient 
period.        
Lead-in Diet 
Following completion of the pretesting, subjects completed a controlled 7-day lead-in 
diet.  The lead-in diet allowed subjects to adapt to a new level of protein intake, so that nitrogen 
balance measurements made during the inpatient stay would not reflect an acute adaption to a 
new level of protein intake.  During the lead-in diet period, subjects arrived every morning at the 
Colorado State University Nutrition Center for breakfast.  Participants ate breakfast at the 
nutrition center under the supervision of study staff.  Food for the remainder of the day was 
prepared and given to the subjects in a cooler.  Subjects were instructed to eat only the food 
given to them by the study staff and to eat all of the food given to them.  If the subjects were 
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unable to eat any of the food provided to them, they brought the food back with them the 
following day so that it could be weighed.  Subjects were instructed to continue their typical 
daily activities throughout the duration of the 7-day lead-in period. 
The lead-in and inpatient diets followed United States Department of Agriculture (USDA) 
nutritional guidelines (UnitedStates.Dept.Agriculture 2005) and were constructed using 
Pronutra software (Viocare, Inc., Princeton, NJ).  The lead-in diets (and all inpatient diets) 
macronutrient breakdown was: 15% protein, 30% fat, and 55% carbohydrate expressed as a 
percentage of total calories.  Subjects remained in energy balance for the duration of the lead-in 
diet.  Total energy intake was calculated using each subject’s RMR, multiplied by an activity 
factor of 1.55, which approximates the activity levels of free living sedentary elderly individuals 
(Pannemans and Westerterp 1995). 
Inpatient period 
The inpatient period involved a 6-day stay at the University of Colorado-Denver CTRC.  
Days 1 and 6 of the inpatient stay were spent in a 12’ x 12’ whole room calorimeter, while days 
2-5 were spent in a regular inpatient room at the CTRC.  During days 2-5, subjects were 
permitted to leave their room twice a day for 30 minutes.  During the inpatient stay, subjects 
were not permitted to perform any exercise other than the one hour of prescribed cycling.  
Subjects were only allowed to eat the food that was provided to them by study staff.  Subjects 
were permitted to consume water ad libitum, and were allowed to request additional non-
caloric, non-caffeinated beverages.  Blood samples were obtained in the fasted state on Days 1, 
3, and 6.  Subjects were weighed in their hospital gowns on the same scale each morning.  
 Each subject completed two, 3-day trials in a randomized crossover design.  Every day at 
16:30, subjects completed one hour of cycling exercise at 55% of their VO2max.  The exercise was 
performed on a Lode Corival bicycle ergometer (Lode, Groningen, The Netherlands).  Subjects 
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recorded their heart rate every 15 minutes during exercise using a heart rate monitor (Polar FS1, 
Lake Success, NY).  The exercise was intended to simulate a brisk walk, which was well tolerated 
by all subjects. 
 Immediately following the daily exercise bout, a post-exercise beverage was consumed. 
During the PRO+CHO phase, a 248-kcal chocolate milk drink which contained 15.3 g protein, 
43.6 g carbohydrate, and 1.3 g fat (330g skim milk, 4.0g whey protein, and 42g chocolate syrup) 
was consumed immediately post-exercise.  During the CHO phase a 247-kcal carbohydrate 
beverage, which contained 0.0g protein, 63.51g carbohydrate, 0.06g fat was consumed 
immediately post-exercise.  During the PRO+CHO trial, the CHO beverage was consumed as a 
snack at 10:00 and during the CHO trial, the PRO+CHO beverage was consumed as a snack at 
10:00.  The order in which subjects completed each trial was randomized. 
 The diets for each 3-day trial were reproduced and identical in caloric intake, 
macronutrients, and foods consumed.  The diet plans for Day 1, 2, and 3 were repeated on Day 
6, 4, and 5, respectively (Table 3.2 provides a sample inpatient diet plan).  The only difference 
between trials was the timing of intake of the protein beverage.  Similar to the lead-in diet, the 
inpatient diet’s percentage of total kilocalories for each macronutrient was: 55% carbohydrate, 
30% fat, and 15% protein.  All study diets corresponded with the USDA’s acceptable 
macronutrient distribution ranges (10-35% protein, 20-35% fat, and 45-65% carbohydrate) 








 Table 3.2 Sample inpatient diet plan 
 
 In order to plan the diets for the inpatient period, total daily energy expenditure was 
estimated.  An activity factor of 1.30-1.35 was multiplied by the subjects RMR for the room 
calorimeter days, and an activity factor of 1.40-1.45 was multiplied by the subjects RMR for the 
non-calorimeter days (Days 2-5) (Jordan, Melanson et al. 2010).  A lower activity factor was used 
for calorimeter days because activity levels are reduced when confined to the calorimeter room.  
Exercise energy expenditure (EE) was estimated from the steady-state VO2 data (measured 
during pre-testing) and an additional 20% of exercise calories were added in order to account 
for excessive post-exercise oxygen consumption (EPOC) (Melanson, Gozansky et al. 2009).  
Equation 3.2 was used to predict total daily energy expenditure (TDEE) for calorimeter room and 






Diet: Breakfast (B), Snacks (S), Lunch (L), Dinner (D) 
1 (CHO)      
Cal room 
1896 B-oatmeal    S- chocolate milk   L-salad  S- CHO beverage  D-spaghetti                                                                                                                                                                                                                                                  
2 (CHO) 1988 B-toast       S- chocolate milk      L-soup       S- CHO beverage  D-stir-fry                                                                                                                                                                      
3 (CHO)      1972 B-eggs  S-chocolate milk L-sandwich S-CHO beverage  D-steak/potato                                                                                                                                                                                                                                                         
4(PRO+CHO) 1988 B-toast        S- CHO beverage      L-soup      S- chocolate milk   D-stir fry                                                                                                                                                                                                                                                                                                                                                             
5(PRO+CHO) 1972 B-eggs  S-CHO beverage L-sandwich  S-chocolate milk D-steak/potato                                                                                                                                                                                                                                                                                                                                                           
6(PRO+CHO) 
Cal room 
1896 B-oatmeal  S- CHO beverage   L-salad   S- chocolate milk   D-spaghetti                                                                                                                                                                                                                                                         
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Equation 3.2 Estimation of TDEE  
EE= (Activity factor  x RMR) + (exercise EE + (0.2 x exercise EE))  (Gersovitz, Motil et al. 
1982). 
The calorimeter room was 12’ x 12’ and contained a bed, sink, toilet, bicycle ergometer, 
computer, and television.  Subjects entered the calorimeter room at 07:45 on Days 1 and 6, and 
exited at 07:15 on following morning.  To prevent air from escaping, all meals were passed 
through an air lock that could not be simultaneously opened from the inside and outside.  Daily 
energy expenditure and substrate oxidation were calculated by the difference in gas content 
that was entering and exiting the room.  Since air was exiting the room for analysis, known 
concentrations of O2 and CO2 were continuously pumped into the calorimeter room.  The 
difference in gas concentrations in the incurrent and excurrent airstreams was measured using a 
differential paramagnetic oxygen analyzer (Siemens Oxymat 6E Oxygen Gas Analyzer; Siemens, 
Houston, TX) and a differential infrared carbon dioxide analyzer (ABB Advance Optima Uras 14 
NDIR CO2 Analyzer; ABB, Zurich, Switzerland).  All analyzed gas values were corrected for 
temperature, barometric pressure, and relative humidity (Melanson, Ingebrigtsen et al. 2010).  
Total energy expenditure and substrate oxidation were calculated using oxygen consumption 
and respiratory quotient (Jequier, Acheson et al. 1987).  All measurements were one-minute 
averages.   
During the inpatient stay, subjects wore an accelerometer (Actigraph GT1M, Pensacola, 
FL), which was removed during exercise, sleep, and showering.  Using equations 3.2 and 3.3, 
energy expenditure from activity was estimated from the accelerometer.  The Freedson 
equation (Equation 3.3) was used to estimate energy expenditure for activity counts >1,952 per 
minute.  For activity counts ≤ 1,952 per minute, energy expenditure was estimated using the 
work energy theorem (Equation 3.4) 
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Equation 3.3 Freedson equation (Freedson, Melanson et al. 1998) 
Kcal/min = 0.00094*counts/minute + 0.1346*body mass (kg) – 7.37418 
Equation 3.4 Work-energy theorem 
Kcal/min = 0.0000191*counts/minute*body mass (kg) 
TDEE on calorimeter days was directly measured and non-calorimeter days were 
estimated using equation 3.5. 
Equation 3.5 TDEE on non calorimeter days 
TDEE = RMR + non-exercise EE (from accelerometer) + exercise EE (measured as average 
of 2 days in calorimeter room) + dietary induced thermogenesis (measured as average 
of two days in calorimeter room) 
Energy balance (EB) for the inpatient period was determined using Equation 3.6, with 
energy intake calculated from the dietician.  
Equation 3.6 Daily energy balance 
EB= caloric intake - TDEE 
Daily physical activity level (PAL) was calculated using Equation 3.7, while non-exercise 
PAL was calculated using equation 3.8.  The value for exercise energy expenditure was 
multiplied by 1.2 to account for the additional energy expenditure resulting from EPOC 
(Melanson, Gozansky et al. 2009). 
Equation 3.7 Physical activity level (PAL) 
PAL=TDEE/RMR 
Equation 3.8 Non-exercise PAL. 






 Twenty-four hour urine samples were collected to determine urinary nitrogen.  Urine 
was collected in acid and total volume was measured.  Two 10-ml aliquots per 24-hour 
collection were frozen and stored for later analysis.  Nitrogen was analyzed using an Antek 7000 
Elemental Nitrogen Analyzer (PAC, Houston, TX).  Nitrogen balance was calculated using 
equation 3.9.  Nitrogen intake was calculated as (protein intake (g)/6.25) since 6.25 grams of 
protein contains on average 1 gram of nitrogen.  Nitrogen output is defined as the nitrogen 
excreted in urine and feces plus miscellaneous nitrogen losses (Calloway, Odell et al. 1971).  
Daily miscellaneous nitrogen losses were estimated at 5 mg/kg bw, and fecal nitrogen losses 
were estimated at 2 grams (Calloway, Odell et al. 1971). 
Equation 3.9 Nitrogen balance 
Nitrogen balance (g) = Nitrogen intake – nitrogen output 
Post-testing 
 Approximately one week after the inpatient period, subjects returned to the HPCRL for a 
final DEXA scan and weight measurement.   
Statistical Analysis 
 All statistical analysis were done using GraphPad Prism (version 4.00 for Macintosh, 
Graphpad Software, San Diego, California).  Nitrogen balance data, energy balance data, pre and 
post body weight, pre and post fat free mass, and pre and post body fat were analyzed using 
student’s paired t-tests.  Pearson’s correlation coefficients (r) were used to determine any 
correlations between nitrogen balance and energy balance, or nitrogen balance and relative 
protein intake.  One-way repeated measures ANOVA analyzed diet-related variables within free-
living, lead-in and inpatient diets.  Any differences within the diet-related variables were 
determined using the Student Newman-Keuls post-hoc test.  All variables that were tested have 
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Energy and macronutrient intake 
All study diets followed USDA Nutritional guidelines and were designed based on each 
subjects’ personal preferences.  Total caloric intake during free-living (as reported from 3-day 
diet records), lead-in, and inpatient periods are depicted in Figure 4.1.  Total caloric intake was 
not significantly different between free-living, lead-in, and inpatient diets.  The decrease in total 
caloric intake during the inpatient period reflects the designed 15% negative energy balance for 
each subject.  Figure 4.2 depicts the average macronutrient intakes for subjects under the free-
living, lead-in, and inpatient periods of the study.  Macronutrient intake was not significantly 
different between free-living, lead-in, and inpatient diets.  Similarly, the decrease in energy 
intake during the inpatient period of the diet reflects the 15% negative energy balance of each 
subject. 
Figure 4.1 Energy intake for free-living, lead-in, and inpatient diets   
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Figure 4.2 Macronutrient intakes for the free-living, lead-in, and inpatient diets  
 
Energy expenditure 
PAL and Non-exercise PAL levels were not significantly different between the CHO and 
PRO+CHO trials (Figure 4.3 and Figure 4.4, respectively). 








Figure 4.4 Non-exercise PAL during inpatient CHO and PRO+CHO trials 
 
Energy balance 
Subjects were in energy balance during the lead-in diet.  During the inpatient period, 
subjects were in negative energy balance with a mean daily negative energy balance of -13.96 ± 
1.82% for the CHO trial, and -14.01±1.81% for PRO+CHO trial (Figure 4.5A).  Energy balance was 
not significantly different between the CHO and PRO+CHO trials (p=0.29).  On average, subjects 
were in -284.37±34.68 kcal during the CHO trial and -291.14±48.42 kcal during the PRO+CHO 
trial (Figure 4.5B).  Additionally, energy balance between Days 1-3 (trial 1) and Days 4-6 (trial 2) 
was not significantly different (p=0.10) (Figure 4.6). 




Figure 4.6 Mean inpatient energy balance on Days 1-3 and Days 4-6 
 
Weight and body composition 
 Body weight did not significantly change from pre (67.2±4.4 kg) to post (66.7±4.3 kg) 
(p=0.051) although there was a strong trend.  Additionally, body fat percentage did not 
significantly change from pre (33.2±1.7%) to post (34.0±2.2%) (p=0.18), nor did fat free mass 
(pre: 44.0±3.5 kg and post: 43.5±3.9 kg) (p=0.24).  The tracking of individual daily body weight 
during the inpatient period is shown in Figure 4.7.  Mean body weight decreased slightly from 
inpatient Day 1 (66.21±4.29kg) to Day 6 (65.60±4.31kg), indicating subjects were in negative 
energy balance. 




Nitrogen Balance (NBAL) 
 Three-day average nitrogen balance was not significantly different between the CHO 
and the PRO+CHO trials (p=0.28) (Figure 4.8).  The mean nitrogen balance for the CHO trial was -
0.070±1.644 g nitrogen (N), and 0.097±1.664 g N in the PRO+CHO trial.  Mean nitrogen balance 
data for the CHO and PRO+CHO trials for individual subjects is presented in Figure 4.7.  
Additionally, there was not a significant difference in nitrogen balance between Days 1-3 and 
Days 4-6 (p=0.245) (Figure 4.9).  Even though subjects were in negative energy balance, nitrogen 
balance was not different from zero.   
Figure 4.8 3-day mean NBAL during CHO and PRO+CHO trials
 





Figure 4.10 Mean NBAL during Days 1-3 and Days 4-6 
 
Combined data for negative, even, and positive energy balance studies 
 Data from all three energy coherts (negative, even, positive) of the study were 
combined.  When the data from all three energy cohorts were combined, nitrogen balance was 
significantly greater in the PRO+CHO trial (0.851±0.291 g N) than the CHO trial (0.419±0.294 g N) 
(p=0.01) (Figure 4.11).  
Figure 4.11 Mean NBAL in CHO and PRO+CHO trials in all studies combined (negative, even, and 
positive energy balance) 
 
Data from all three energy cohorts were then re-stratified inorder to make further comparisons 
between nitrogen balance and energy balance.  Six-day mean energy balance was used to 
restratify the groups.  Less than 0.0% energy balance was considered negative, and greater than 
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0.0% energy balance was considered positive.  Overall, there were nine subjects in the negative 
energy balance group and fourteen subjects within the positive energy balance group.   
Re-stratified Energy Balance 
 After restratification, the resulting energy balance was significantly different  between 
the negative and positive energy balance groups (p<0.0001).  Mean negative energy balance 
was -13.39±2.41%, and mean positive energy balance was 12.85 ± 1.96% (Figure 4.12). 
Figure 4.12 Mean energy balance in re-stratified negative and positive energy balance groups 
 
Re-stratified Nitrogen Balance 
 The mean difference (PRO+CHO trial  minus CHO trial) in nitrogen balance between the 
CHO and PRO+CHO trial was not significant (p=0.244).  However, the mean difference in 
nitrogen balance was significantly different for both the CHO trial (p=0.009), and the PRO+CHO 
trial (p=0.002).  The mean nitrogen balance values for the CHO trial were  -0.429±0.418g 
nitrogen for the negative group, and 0.964±0.336g nitrogen for the positive group (Figure 4.13).   
The mean nitrogen balance values for the PRO+CHO trial were -0.151±0.473g nitrogen for the 





Figure 4.13 Mean NBAL in re-stratified negative and positive groups during CHO trial (p=0.009) 
and PRO+CHO trial (p=0.002) 
 
There was not a significant difference in mean nitrogen balance between the CHO and 
PRO+CHO trial in the re-stratified negative energy balance group (p=0.178)(Figure 4.14A).  
However, there is a significant difference between the CHO and PRO+CHO trial in the re-
stratified positive energy balance group (0.964±0.336g nitrogen for the CHO trial, and 
1.494±0.256g nitrogen for  the PRO+CHO trial)(p=0.016) as depicted in Figure 4.14B.   
Figure 4.14 Mean nitrogen balance in CHO and PRO+CHO trials for re-stratified negative energy 





Re-stratified Energy balance and Nitrogen Balance 
 Daily energy balance was significantly correlated with daily nitrogen balance (R2=0.065, 
p=0.003) (Figure 4.15).  Within the PRO+CHO trial, daily energy balance is significantly correlated 
with daily nitrogen balance (R2=0.115, p=0.004)(Figure 4.15).  However, within the CHO trial, 
energy balance was not significantly correlated to nitrogen balance (R2=0.035, p=0.127)(Figure 
4.15). 
Figure 4.15 Correlation between daily energy balance and daily NBAL in Combined Trials 
(p=0.003), CHO trial (p=0.127), and PRO + CHO trial (p=0.004)   
 
Re-stratified Protein intake and Nitrogen Balance 
 Daily protein intake (g/kg bw) for all subjects within the three coherts was not 
significantly correlated with daily nitrogen balance (R2=0.003, p=0.490) (Figure 4.16). However, 
when the data is further partitioned by sex, daily protein intake (g/kg bw) was significant 
correlated with nitrogen balance for both males (R2=0.328, p=<0.0001)(figure 4.16) and females 
(R2=0.042, p=0.028)(Figure 4.16).  For both males and females, nitrogen balance was then 
correlated to daily protein intake (g/kg bw) for the CHO and PRO+CHO trials.  In females, daily 
protein intake (g/kg bw) was not significantly correlated to daily nitrogen balance in either the 
CHO (R2=0.051, p=0.091), or the PRO+CHO trial (R2=0.035, p=0.162). However, in males, daily 
protein intake (g/kg bw) was significantly correlated to daily nitrogen balance in both the CHO 
(R2=0.252, p=0.021)(Figure 4.17), and the PRO+CHO trial (R2=0.435, p=0.001)(Figure 4.17). 
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Figure 4.16 Correlation between daily protein intake (g/kg bw) and daily NBAL for all subjects 
(p=0.490), females (p=0.028), and males (p=<0.0001)  
 
Figure 4.17 Correlation between daily protein intake (g/kg bw) and daily NBAL for men during 














 The current study investigated the timing of protein consumption in relation to 
a bout of moderate aerobic exercise on nitrogen balance.  Older individuals completed two 3-
day trials with only the timing of protein consumption during the day differing between the two 
conditions.  Contrary to our initial hypothesis, nitrogen balance did not significantly differ in 
older individuals in negative energy balance when protein was consumed immediately after 
moderate aerobic exercise rather than earlier in the day.  Previously, our lab showed that 
nitrogen balance was significantly greater in older individuals in energy balance when protein 
was consumed immediately after moderate aerobic exercise compared to earlier in the day.  
Together these results indicate that energy balance is an important determinant of the anabolic 
effect of protein feeding.  Moreover, older individuals were able to maintain nitrogen balance 
by timing nutrient intake immediately after aerobic exercise, despite being in negative energy 
balance.  To our knowledge, our study was the first to investigate the combined effects of 
varying energy balance and the timing of protein intake on nitrogen balance in older individuals.    
 Nitrogen balance is closely related to energy balance such that nitrogen balance is 
better maintained when caloric intake is adequate, as a negative nitrogen balance results when 
energy intake is reduced (Todd, Butterfield et al. 1984).  During caloric restriction, protein 
breakdown increases the availability of amino acids that are oxidized as energy and thus limits 
the availability of amino acids for protein synthesis.   When caloric intake is inadequate, aerobic 
exercise can increase nitrogen balance (Todd, Butterfield et al. 1984).  Consistent with this, in 
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the current study older individuals were able to maintain nitrogen balance for both the CHO and 
PRO+CHO trials despite being in approximately 14% negative energy balance.  Since loss of lean 
body mass occurs when individuals are in negative nitrogen balance (Friedlander, Braun et al. 
2005), maintaining nitrogen balance while in negative energy balance could reduce the loss of 
lean body mass and thus attenuate the progression of sarcopenia and wasting.        
 The daily exercise completed by participants during the inpatient stay was one hour of 
moderate intensity (55% VO2max) cycling.  The exercise intensity and duration was well-tolerated 
by all subjects, and the inpatient PAL was consistent with older populations (Pannemans and 
Westerterp 1995).  Exercise at 55% of VO2max provides an effective anabolic stimulus, as aerobic 
exercise at only 40% of VO2max can increase muscle protein synthesis (Sheffield-Moore, Yeckel et 
al. 2004).  Additionally, exercise at 55% of VO2max simulates a brisk walking pace and since older 
individuals most commonly choose walking as exercise (McPhillips, Pellettera et al. 1989), the 
proposed exercise intervention is practical for an older population. 
          All study diets followed USDA dietary recommendations for the percentage of total 
kilocalories for each macronutrient (45-65% carbohydrate, 20-35% fat, and 10-35% protein) 
(UnitedStates.Dept.Agriculture 2005) and were: 55% carbohydrate, 30% fat, and 15% protein.  
Inpatient protein intake was 1.1 g/kg bw, which exceeds the 0.8 g/kg bw  recommendation for 
older individuals; however, it is still representative of a typical protein intake for an older 
population (Millward and Roberts 1996).  Mean self-reported habitual protein intake was 
1.3±0.1 g/kg bw, thus the lead-in diet allowed study participants to adjust to the new level of 
protein intake.  Furthermore, mean nitrogen balance did not differ between inpatient Days 1-3 
and Days 4-6, which indicates that participants were habituated to the inpatient protein intake.  
 Older individuals have a blunted muscle protein synthesis response to anabolic signals, 
compared to younger individuals, as the anabolic response of skeletal muscle proteins to 
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essential amino acids is reduced in the elderly (Volpi, Kobayashi et al. 2003).  However, 
increasing the proportion of leucine allows for optimal stimulation of muscle protein synthesis in 
older individuals (Katsanos, Kobayashi et al. 2006).  Chocolate milk was chosen for this study as 
the protein source because milk contains adequate leucine, which enhances protein synthesis 
through the mTOR pathway (Anthony, Anthony et al. 2000).  Moreover, milk consists of both 
whey and casein proteins (Jenness 1979).  Whey protein results in an acute increase in protein 
synthesis (Boirie, Dangin et al. 1997), whereas  casein protein results in a minor increase in 
protein synthesis and a significant decrease in protein breakdown (Boirie, Dangin et al. 1997).  
Thus, milk can enhance protein accretion by increasing protein synthesis and down-regulating 
protein breakdown.  In this study, the chocolate milk beverage consisted of 11.3 g protein within 
the skim milk, supplemented with 4 g of whey protein.  Overall, the chocolate milk beverage 
contained 15.3 g protein including 6.8 g essential amino acids with 1.7 g leucine.  The chocolate 
milk also consisted of 43.6 g carbohydrate.  Consumption of carbohydrate combined with 
protein after aerobic exercise increases whole body net protein balance and muscle FSR more 
than an isocaloric amount of carbohydrate alone (Howarth, Moreau et al. 2009).  The 
consumption of chocolate milk as a post-exercise beverage would be practical for an older 
population as it is an easily attainable protein source.   
Combined data from all three energy cohorts 
  Data from all three energy coherts (negative, even, positive) of the study were 
combined in order to further analyze the relationship between energy balance and the timing of 
protein intake on nitrogen balance.  Combining the data from all three energy cohorts is 
appropriate since energy balance typically varies from day to day.  When the data from the 
three cohorts were combined mean nitrogen balance was significantly greater when protein and 
carbohydrates are consumed immediately after exercise rather than earlier in the day.  
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Therefore, consuming protein and carbohydrate immediately after exercise is a valid approach 
to increase nitrogen balance in older individuals.   
The subjects were also stratified into a negative or positive energy balance group in 
order to analyze nitrogen balance for both the PRO+CHO and CHO trials.  Six-day mean energy 
balance was used to restratify the groups.  Any 6-day mean energy balance that was less than 
0.0% was placed into the negative energy balance group and any 6-day mean nitrogen balance 
that was greater than 0.0% was placed into the positive energy balance group.  Overall, the new 
negative energy balance group contained nine subjects and the positive energy balance group 
contained fourteen subjects.  Three subjects were excluded from the re-stratification because 
the accelerometer malfunctioned during their inpatient stay and therefore six-day mean energy 
balance was not available for the three subjects.    
Energy Balance and Nitrogen Balance 
 Within the re-stratified negative energy balance group, there was not a significant 
difference in nitrogen balance between the PRO+CHO and CHO trials.  Although the lack of 
significance between the PRO+CHO and CHO trials is consistent with the results from the 
negative energy balance cohort, these results differ from previous research by Roy et al. (Roy, 
Luttmer et al. 2002).  In young female athletes in exercise-induced negative energy balance, 
timing nutrient intake immediately after exercise, rather than earlier in the day, resulted in 
greater nitrogen balance with a strong trend toward significance (p=0.06)(Roy, Luttmer et al. 
2002).  Within the re-stratified positive energy balance group, nitrogen balance was significantly 
different between the PRO+CHO and CHO trials.  Moreover, across the re-stratified energy 
groups, there was a significant correlation between daily energy balance and nitrogen balance.  
Taken together, our results indicate that timing protein intake immediately after aerobic 
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exercise has a greater influence on nitrogen balance when in positive energy balance rather 
than negative energy balance.   
Within the re-stratified energy balance groups, mean nitrogen balance was significantly 
different between the negative and positive energy balance groups for both the CHO trial and 
the PRO+CHO trial.  The increase in nitrogen balance was more prominent in the PRO+CHO trial 
than the CHO trial, which is consistent with previous research (Howarth, Moreau et al. 2009).  
Howarth et al. found that consuming protein with carbohydrate after aerobic exercise increases 
whole body net protein balance more than an isocaloric amount of carbohydrate alone 
(Howarth, Moreau et al. 2009).  Thus, consuming protein with carbohydrate after aerobic 
exercise increases nitrogen balance more than consuming carbohydrate alone.         
Across the re-stratified energy groups, there was a significant correlation between 
energy balance and nitrogen balance when protein and carbohydrate was consumed post-
exercise (PRO+CHO group).  Within the CHO group, there was not a significant correlation 
between daily energy balance and daily nitrogen balance.  These results indicate that energy 
balance is more predictive of nitrogen balance when protein with carbohydrate is consumed 
immediately post-exercise compared to an isocaloric amount of only carbohydrate.   
Protein Intake and Nitrogen Balance  
Daily protein intake (g/kg bw) was not significantly correlated with daily nitrogen 
balance.  However, when the subjects were split by sex, daily protein intake was significantly 
correlated with nitrogen balance in males (R2=0.3279, p=<0.0001).  Similarly, in females daily 
protein intake was significatly correltated with nitrogen balance (R2=0.04219, p=0.0284).  These 
results indicate that total daily protein intake (g/kg bw) is predictive of nitrogen balance when 
seperated by sex.  Moreover, the male and female groups were further divided by PRO+CHO 
and CHO trials.  We found that in males, daily total protein intake is significantly correlated with 
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nitrogen balance in both the PRO+CHO (R2=0.4346, p=0.0012) and CHO trials (R2=0.2515, 
p=0.0205).  In females, total protein intake was not significantly correlated with nitrogen 
balance for either PRO+CHO or CHO trials.  These results suggest that in older males, protein 
intake is more predictive of nitrogen balance when protein with carbohydrate is consumed post-
exercise, rather than an isocaloric amount of only carbohydrate.  To our knowledge, the sex 
related differences between protein intake and protein timing on nitrogen balance is a novel 
finding.  The sex related differences on nitrogen balance may be due to differences in the rates 
of protein synthesis during basal conditions between older men and older women (Smith, 
Atherton et al. 2008).   
Limitations 
Use of the nitrogen balance technique may result in inflated nitrogen retention values 
(Kopple 1987).  Nitrogen intake can be overestimated if any food is not completely consumed.  
However, participants were instructed to consume all foods and consumption of the inpatient 
meals was closely monitored to ensure that all food and beverages were consumed.  
Furthermore, nitrogen intake is estimated based on total protein intake, with 6.25 grams of 
protein containing 1 gram of nitrogen.  However, 6.25 grams of protein do not always contain 1 
gram of nitrogen, as 6.25 is an average based on protein quality.  Inadequate collection of any 
excreted nitrogen can also contribute to overestimated nitrogen retention.  Collecting 
miscellaneous nitrogen losses can be quite challenging and therefore relies on estimates.  Thus, 
variability between individuals could contribute to overestimated nitrogen balance.  However, 
the same foods were consumed during both trials, and any measurement error would occur 
during both conditions to the same extent.  Therefore, if nitrogen balance was overestimated, 
the difference in nitrogen balance between the two conditions would still remain constant.   
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Despite limitations, the nitrogen balance technique can be a useful technique for 
studying whole body protein turnover in aging populations.  The contribution of muscle protein 
to whole body protein metabolism is significantly reduced in the elderly.  Consequently, the 
contribution of non skeletal muscle protein, especially visceral tissue whose rates of protein 
turnover are known to be more rapid, is proportionally greater with aging (Morais, Chevalier et 
al. 2006).  Thus, the nitrogen balance technique with its noninvasive nature makes it a relatively 
easy and appropriate method to determine long term changes in whole body protein turnover 
in response to exercise and nutrition interventions in older individuals.  
An error in the nutritional information for the carbohydrate beverage during the energy 
balance cohort of the study resulted in an additional 159 grams of carbohydrate in the CHO 
beverage.  Therefore, subjects in the even energy balance cohort received an additional 159 
calories post-exercise in the CHO trial compared to the PRO+CHO trial.  Since the effect of 
carbohydrate on protein synthesis depends on the amount consumed (Miller, Tipton et al. 
2003), nitrogen balance for the ten subjects in the CHO condition may have been more positive 
than if the CHO beverage was isocaloric with the PRO+CHO beverage or with the other CHO 
beverage.     
Conclusions and future directions 
 In summary, the current study investigated whether timing protein intake after 
moderate aerobic exercise can improve nitrogen balance in older individuals in negative energy 
balance.  We hypothesized that nitrogen balance would increase when protein was consumed 
post-exercise.  However, contrary to our initial hypothesis, nitrogen balance did not significantly 
differ when protein was consumed immediately after exercise rather than earlier in the day.  
Previously, our lab showed that nitrogen balance was significantly greater in older individuals in 
energy balance when protein was consumed immediately after aerobic exercise compared to 
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earlier in the day.  Together these results indicate that energy balance is an important 
determinant of the anabolic effect of protein feeding and therefore must be considered when 
using the NBAL method.   
We found significant differences with protein intake on nitrogen balance between 
sexes; therefore, future studies should investigate whether nitrogen balance differs between 
males and females under various nutritional and exercise interventions.  Additionally, future 
studies should explore whether increases in nitrogen balance observed within this study can be 
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Consent Form Approval              
Date:                                        Valid For Use Through:___________ 
 
SUBJECT CONSENT FORM 
 
COLORADO MULTIPLE INSTITUTIONAL REVIEW BOARD 
Protocol #08-0640 
 
And CSU IRB 
Protocol # 08-187H 
 
“Consumption of milk after physical activity - rethinking protein recommendations in older 
individuals” 
 
PRINCIPAL INVESTIGATOR: Edward L. Melanson, Ph. D. and Benjamin F Miller, PhD 
 
Version #2 
Last Updated: April 16, 2010 
 
 
You are being asked to be in a research study.  This form provides you with information about 
the study. A member of the research team will describe this study to you and answer all of your 
questions. Please read the information below and ask questions about anything you don’t 
understand before deciding whether or not to take part.  
 
Why is this study being done? 
This study plans to learn more about how to prevent muscles from wasting with the aging 
process.  We would like to use a simple strategy using exercise and 
nutrition.  What this study seeks to determine is when you have protein can be just as important 
as how much protein you receive.  In the two study periods what you eat will be the same, but 
when you eat it will be different.  
You are being asked to be in this research study because you are a healthy individual aged 55-
75.   
Other people in this study 
Up to 40 people from your area will participate in the study.  
What happens if I join this study? 
If you join the study, you will first complete a physical screening including a screening for heart 
disease at Colorado State University. We will ask you to answer some questions about your past 
and current participation in exercise.  Your body weight, height, and body composition will be 
measured by laying in a bed and being scanned.  Your gender and date of birth will also be 
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recorded.  A 3 tsp sample of blood will be taken for screening purposes.  Before undergoing the 
sampling procedures, you will be asked a few questions relating to your present state of health, 
current medication and past medical history.  This is to exclude the presence of any condition or 
medication that might prolong your bleeding time or make the blood sampling unsafe for you.  
This visit will take approximately 30 minutes. 
You will also undergo cardiac screening in the presence of a cardiologist.  This will involve the 
placement of ten collecting electrodes on your chest that will be connected to an 
electrocardiogram (ECG).  You will then be asked to walk on a treadmill, slowly at first and 
progressively faster until the cardiologist asks you to stop.  This test will take approximately 45 
minutes.  If anything adverse is found in any of the medical screening, you will be advised.   
In the seven-day period leading up to the study, we will provide you with all of your food from 
the Department of Food Science and Human Nutrition at CSU.  The food will be normal food 
tailored to your diet, but we ask that you only consume this food.   
For the study, you will report to the general clinical research center (GCRC) at the Colorado 
Health Sciences Center the night before the start of the study and sleep over night.  You will 
then remain in the GCRC for six days.  During this stay you will be asked to exercise once per day 
for one hour on a bike.  The exercise intensity will be slightly more than that required to 
complete a brisk walk.   During the entire stay you will also be fed a controlled diet that will be 
slightly less (approximately 200 kcal) than your normal calorie and protein intake and you will 
wear a monitor to measure the amount of activity.  You will receive a protein supplement either 
in the morning or after your exercise bout and when you receive the protein supplement will 
switch half way through the stay. Throughout the study all your urine will be collected for 
analysis. In addition, we will collect a small blood sample (2 tsp) at three different times.  For a 
24 hr period at the beginning of the study and at the end of the study, you will reside in a room 
that will measure the rate your body is using energy.  This room contains everything you will 
need for normal living, but is specially designed for our measurements.  After you exit the 
special room on the last day, you will receive one more body scan for body composition.  
In total your commitment to the study is a half-day for screening, seven days with normal living 
and food provision, and a six-day (seven-night) stay at the GCRC.   
What are the possible discomforts or risks? 
In this study we will need to get a total of about 9 teaspoons of blood from you. We will get 
blood by putting a needle into one of your veins and letting the blood flow into a glass tube.  
You may feel some pain when the needle goes into your vein.  A day or two later, you may have 
a small bruise where the needle went under the skin.   If you have not participated in a regular 
exercise program before, you may experience some discomfort with the exercise bout including 
muscle soreness or labored breathing.  You may experience discomfort (boredom) associated 
with a prolonged stay in our facility and special room.  However, all efforts will be made to 
ensure your comfort including access to television, internet, and daily exercise.   
Other possible risks include a small risk (less than 1 in 10 000) of death due to a cardiac event 
during exercise screening.   There are also risks of fatigue and muscle strains.  You may 
experience temporary breathlessness or dizziness towards the end of the test.  These feelings 
77 
 
are transient and pass once the test is finished.  During your daily exercise there is also a risk of 
cardiac complications but in individuals with good cardiac health this risk is extremely low (1 in 1 
000 000).   
As part of this study we will perform two DEXA scans of your body.  DEXA is a way of looking 
inside the body by using X-rays.  X-rays are a type of radiation.  Your natural environment has 
some radiation in it.  This DEXA will give you about the same amount of radiation that you would 
get from your environment in four days.   
This study may include risks that are unknown at this time 
What are the possible benefits of the study? 
This study is designed for the researcher to learn more about potential non-pharmaceutical 
treatments for the prevention of muscle wasting with aging.  We want to incorporate easy-to-
follow strategies for improved muscular health.  You will receive a medical and cardiac screen 
and will obtain information on your body composition.  
This study is not designed to treat any illness or to improve your health.  Also, there may be 
risks, as discussed in the section describing the discomforts or risks. 
Who is paying for this study?  
This research is being funded by the Colorado Agricultural Experiment Station with the mission 
of increasing the quality of foods in Colorado.   
Will I be paid for being in the study?   
You will not be paid for the screening tests or travel expenditures, but you will be paid $300 for 
completion of the GCRC stay.  If you leave the study early, or if we have to take you out of the 
study, you will be paid $40 for each overnight stay. 
It is important to know that payments for participation in a study are taxable income.  
Will I have to pay for anything? 
It will not cost you anything to be in the study. 
Is my participation voluntary? 
Taking part in this study is voluntary.  You have the right to choose not to take part in this study.  
If you choose to take part, you have the right to stop at any time.  If you refuse or decide to 
withdraw later, you will not lose any benefits or rights to which you are entitled.  
Can I be removed from this study?  
The study nurse, Rebecca Benson PA/RN, or her supervising physician, Robert Eckel, MD, may 
decide to stop your participation without your permission if the  
study nurse/doctor thinks that being in the study may cause you harm, or for any other reason.  
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What happens if I am injured or hurt during the study?  
You should inform your care provider(s) if you decide to participate in this research study. If you 
have questions about injury related to the research, you may call the study coordinator, Edward 
Melanson, Ph.D. at (303) 724-0935 and/or your private physician. Edward Melanson, Ph.D. 
should be informed about any injury you experience while you take part in this study.  If you are 
hurt by this research, we will give you medical care of you want it, but you will have to pay for 
the care that is needed. 
Who do I call if I have questions? 
The researchers carrying out this study are Dr. Ed Melanson and Dr. Benjamin Miller. You may 
ask any questions you have now. If you have questions later, you may call Dr. Melanson at 303-
724-0935 or Dr. Miller at 970-491-3291. You will be given a copy of this form to keep.   
 
You may have questions about your rights as someone in this study. You can call Dr. Melanson 
at 303-724-0935 or Dr. Miller at 970-491-3291 with questions.  You can also call the Colorado 
Multiple Institutional Review Board (COMIRB).  You can call them at 303-724-1055.  
 
The main person to talk to if you have questions about this study is Dr. Melanson at 303-724-
0935 or Dr. Miller at 970-491-3291.  You can also talk to a Subject Advocate at the General 
Clinical Research Center (GCRC)/ the Clinical Translation Research Center (CTRC).  The phone 
number there is 720-848-6662.  
Who will see my research information? 
We will do our best to keep your research records private. But there are some people and 
agencies who will be allowed to see them.  These include:  
 
• Federal offices such as the Food and Drug Administration (FDA) that protect research 
subjects like you. 
• People at the Colorado Multiple Institutional Review Board (COMIRB) 
• The study doctor and his/her team of researchers. 
• Officials at Colorado State University or the Colorado Health Sciences Center who are in 
charge of making sure that we follow all of the rules for research 
 
We might talk about this research study at meetings.  We might also print the results of this 
research study in relevant journals.  But we will always keep the names of the research subjects, 




We will ask you to sign a different form that talks about who can see your research records.  
That form is called a HIPAA form.  It will mention companies and universities who will see your 
research records.  
  
You have the right to request access to your personal health information from the Investigator. 
[To ensure proper evaluation of test results, your access to these study results may not be 
allowed until after the study has been completed – if applicable]. 
 
This HIPAA authorization does not expire.  However, you may withdraw this authorization for 
use and disclosure of your personal health information by providing written request to the 
Investigator. If you withdraw this authorization, the Institution, the Investigator, the research 
staff, and the research Sponsor will no longer be able to use or disclose your personal health 
information from this study, except so far as that they have already relied on this information to 
conduct the study. 
Agreement to be in this study 
I have read this paper about the study or it was read to me.  I understand the possible risks and 
benefits of this study.  I know that being in this study is voluntary.  I choose to be in this study: I 
will get a copy of this consent form. 
Signature:         Date: _____ 
 
Print Name:         
 
Consent form explained by:                  Date:   
 
Print Name:         
 


















































Authorization To Use or Release 
Health Information About Me 
For Research Purposes 
Authorization B: Enrollment into Research 
 
Study Title: Consumption of milk after physical 
activity - rethinking protein recommendations 
in older individuals 
 
 
COMIRB Number: 08-0460 
 
I (Subject’s Full 
Name) authorize 
 
  (PI or Physician Name) and 
staff members of 
 
 (Facility Name) working for him/her to use the 
following health information about me for research:(Please check the appropriate boxes.  
NOTE:  If a category is checked “yes” and a line follows the category, you MUST describe the type 
of the procedures done.) 
 
No Yes 
 Name and/or phone number   
 Demographic information (age, sex, ethnicity, address, etc.) 
 Diagnosis(es) 
 History and/or Physical 
 Laboratory or Tissue Studies:   
 Radiology Studies:   
 Testing for or Infection with Human Immunodeficiency Virus (HIV) (or results)   
 Procedure results:    
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 Psychological tests:   
 Survey/Questionnaire:   
 Research Visit records 
 Portions of previous Medical Records that are relevant to this study 
 Billing or financial information 
 Drug Abuse  
 Alcoholism or Alcohol abuse  
 Sickle Cell Anemia  
 Other (Specify):   
For the Specific Purpose of 
 Collecting data for this research project 
 Other*   





If my health information that identifies me is also going to be given out to others outside the 
facility, the recipients are described on the next page(s). 




The PI (or staff acting on behalf of the PI) will also make the following health information 
about me available to:  (check all that apply and describe the type of the procedures done 
where applicable)  
Recipient   (name of person or group)  
 
No Yes 
All Research Data Collected in this Study (if you check this box Yes, no other boxes need to 
be checked in this section) 
All Research Data Collected in this Study except for name, phone number, and/or address 
(if you check this box Yes, no other boxes need to be checked in this section) 
 
 
  Name and phone number   
  Demographic information (age, sex, ethnicity, address, etc.) 
  Diagnosis(es) 
  History and Physical 
  Laboratory or Tissue Studies:   
  Radiology Studies:   
 Testing for or Infection with Human Immunodeficiency Virus (HIV) (or results)  
 Procedure results:   
  Psychological tests:   
  Questionnaire/Survey:   
  Research Visit records 
  Portions of previous Medical Records that are relevant to this study 
  Billing/Charges  
 Drug Abuse  
 Alcoholism or Alcohol  
 Sickle Cell Anemia  




For the Specific Purpose of 
 Evaluation of this research project 
 Evaluation of laboratory/tissue samples 
 Data management 
 Data analysis 
 Other*:   
*Cannot say “for any and all research”, “for any purpose”, etc. 
For additional Recipients, copy this page as needed. 
I give my authorization knowing that: 
1. I do not have to sign this authorization.  But if I do not sign it the researcher has the right to 
not let me be in the research study.   
2. I can cancel this authorization any time.   
1. I have to cancel it in writing.   
2. If I cancel it, the researchers and the people the information was given to will still be 
able to use it because I had given them my permission, but they won’t get any more 
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information about me.   
3. If I cancel my authorization, I may no longer be able to be in the study. 
4. I can read the Notice of Privacy Practices at the facility where the research is being 
conducted to find out how to cancel my authorization. 
5. The records given out to other people may be given out by them and might no longer be 
protected.  
6. I will be given a copy of this form after I have signed and dated it.   
 
This authorization will expire on:  (Date) OR 
  The end of the research study 
  Will not expire 
  
      (Describe dates or circumstances under which the authorization will expire.) 
 
 






Subject’s Signature       Date 
  
Signature of Legal Representative (If applicable)               Date 
  
Name of Legal Representative (please print 
  





Site: Colorado State University, Dr. Benjamin Miller 
 
I give my authorization knowing that: 
7. I do not have to sign this authorization.  But if I do not sign it the researcher has the right to 
not let me be in the research study.   
8. I can cancel this authorization any time.   
9. I have to cancel it in writing.   
10. If I cancel it, the researchers and the people the information was given to will still be 
able to use it because I had given them my permission, but they won’t get any more 
information about me.   
11. If I cancel my authorization, I may no longer be able to be in the study. 
12. I can read the Notice of Privacy Practices at the facility where the research is being 
conducted to find out how to cancel my authorization. 
13. The records given out to other people may be given out by them and might no longer be 
protected.  
14. I will be given a copy of this form after I have signed and dated it.   
 
This authorization will expire on:  (Date) OR 
  The end of the research study 
  Will not expire 
  
      (Describe dates or circumstances under which the authorization will expire.) 
 
 









Signature of Legal Representative (If applicable)                            Date 
  
Name of Legal Representative (please print) 
  












































DEPARTMENT OF HEALTH AND EXERCISE SCIENCE 
 




NAME__________________________       GENDER___________  DATE______________ 
 







1. How often do you exercise?  ______________ times/week 
 
2. Describe the intensity of your exercise (circle one) 
 1 = none 
 2 = light (e.g. casual walking, golf) 
 3 = moderate (e.g. brisk walking, jogging, cycling, swimming) 
 4 = heavy (e.g. running, high intensity sport activity) 
 
3. What types of exercise do you engage in and how much do you do each session?  
 1 = none 
 2 = walking ________ km or minutes 
 3 = jogging/running __________  km or minutes 
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 4 = swimming ___________ meters or minutes 
 5 = cycling ____________  km or minutes 
 6 = team sports (rugby, cricket, soccer, etc.) __________minutes __________ intensity 
 7 = racquet sports ___________minutes 
 8 = weight training ___________minutes __________# reps ___________# sets 
 9 = other ________________________________________________________________ 
 
4. How much time per week do you spend exercising?  ___________ hours/week 
 
5. Do you measure your heart rate during exercise?  ___________ 
 If yes:   
 a. How high does it get during your typical workout?  __________ beats/min 
 b. What heart rate is maintained throughout most of your workout?   
__________beats/min 
 
6. How long have you had a regular exercise program?_________ 
 
7. What condition or shape do you consider yourself to be in now (in terms of physical 
fitness)? 
 1 = poor 
 2 = fair 
 3 = good 
 4 = excellent 
 
8. Do you or have you ever smoked?  _________ 









10. Has a close blood relative had or died from heart disease or related disorders (Heart  
 Attack, Stroke, High Blood Pressure, Diabetes etc.)? 
 1=Mother 
 2=Father 
 3=Brother - Sister 
 4=Aunt - Uncle 
 5=Grandmother - Grandfather 
 6=None 









 If yes- write the date and value (or if it was normal or abnormal) 
 _________________________________________________________________________ 
 
12. Indicate which of the following apply to you (circle all that apply). 
 1 = high blood pressure 
 2 = high blood fats or cholesterol 
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 3 = cigarette smoking 
 4 = known heart disease or abnormalities 
 5 = family history of heart disease (parents or siblings before age 50) 
 6 = sedentary lifestyle 
 7 = stressful lifestyle at home or at work 
 8 = diabetes mellitus 
 9 = gout (high uric acid) 
            10 = obesity 
 
13. Any medical complaints now (illness, injury, limitations)? 
 1 = yes               If yes, describe completely______________________________________ 
 2 = no                 ___________________________________________________________ 
                                    _____________________________________________________________ 
 
14. Any major illness in the past? 
 1 = yes               If yes, describe completely______________________________________ 
 2 = no                 ___________________________________________________________ 
                                    _____________________________________________________________ 
                                    _____________________________________________________________ 
 
15. Any surgery or hospitalization in the past? 
 1 = yes               If yes, describe completely______________________________________ 
 2 = no                 ___________________________________________________________ 
                                    _____________________________________________________________ 




16. Are you currently taking any medications (prescription or over-the-counter: including 
birth control)? 
 1 = yes               If yes, list drugs and dosages ____________________________________ 
 2 = no                 ____________________________________________________________ 
                                    ______________________________________________________________ 
                                    ______________________________________________________________ 
 
17. Are you allergic to any medications? 
 1 = yes               If yes, list medications__________________________________________ 
 2 = no                ____________________________________________________________ 
                                   ______________________________________________________________ 
                                   ______________________________________________________________ 
 
 
18. Have you ever had any neurological problems? 
 1 = yes                If yes, describe completely______________________________________ 
 2 = no                  ___________________________________________________________ 
                                     _____________________________________________________________ 
 
19. Do you now have, or have you ever had, any of the following? (circle all that apply) 
 1 = heart murmurs 
 2 = any chest pain at rest 
 3 = any chest pain upon exertion 
 4 = pain in left arm, jaw, neck 
 5 = any palpitations 
 6 = fainting or dizziness 
 7 = daily coughing 
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 8 = difficulty breathing at rest or during exercise 
          9 = any known respiratory diseases 
 





20. Do you now have, or have you ever had, any of the following? (circle all that apply) 
 1 = any bone or joint injuries 
 2 = any muscular injuries 
 3 = muscle or joint pain following exercise 
 4 = limited flexibility 
 5 = any musculoskeletal problems which might limit your ability to exercise 
 
 Please describe fully any items you circled______________________________________ 
 ________________________________________________________________________ 
 ________________________________________________________________________ 
 ________________________________________________________________________ 
 
